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We would like to introduce bionanoparticles with their unique multifunctional and self-assembling
properties. Particularly, protein cages like plant viruses or ferritin but also other well-deﬁned self-
assembling protein structural motifs are valuable building blocks with great potential in (bio-)
nanotechnology. A steeply increasing number of research works present promising results and
applications in biomedicine, diagnostics and analytics as well as nanoelectronics. However, the use of
bionanoparticles for hybrid and soft proteinepolymer composite materials has not received high
attention yet. The article will ﬁrst introduce the structural principles of well-deﬁned protein
complexes and exemplarily describe the structure of a few selected plant viruses and ferritin. Then,
the recent progress in chemical or genetically programmed functionalization and the use of the
modiﬁed bionanoparticles for the production of novel nanostructured (hybrid) materials will be
presented. An updated overview of grafting-onto and grafting-from polymerization methods for the
modiﬁcation of proteins and protein complexes will be given as well. The feature closes with some
exciting examples in which bio (in-) organic nanoparticles are employed in analytics, for catalysis and
biomedical applications.
 2010 Elsevier Ltd. Open access under CC BY-NC-ND license .1. Introduction
Miniaturization towards nanoscale structured materials and
devices have become a leading trend in the beginning of this
century. The generation of small structures was traditionally a top-
down process: The application of masks, illumination and etching
steps generated the desired structures on an initially unpatterned
material. To generate even smaller structures than currently
possible with commercially competitive lithographic methods,
bottom-up approaches, i.e. the generation of complex nanoscale
patterns which start from nanoscaled building blocks, have been
developed. By now, an astonishing multitude of materials, ranging
from inorganic to polymeric nanoparticles, biological building
blocks and nanostructured thin ﬁlms with many different elec-
tronic, magnetic, optical and (bio-) chemical properties have been
synthesized and characterized in great detail. The pivotal point is
the directed assembly or self-assembly of these systems into hier-
archically ordered and/or arbitrarily deﬁned structures [1]. Such(G. Jutz), boeker@dwi.rwth-
 BY-NC-ND license.structures can be used in high-resolution soft lithography to
produce next-generation nanoelectronic devices [2,3]. The
production and use of nanostructured and nanoscaled materials
became a key technology in many more ﬁelds e.g. pharmacy [4],
regenerative medicine [5], diagnostics [6], cosmetics [7] or food
technology [8,9].
Progress in nanotechnology is not only aiming at miniaturiza-
tion but also at systems with increased complexity. This is not just
a matter of geometrical structurization but also a matter of speciﬁc
functionalities that are positioned at discrete locations and in
deﬁned distances. Nature and its highly precise mechanisms of
life, mainly based on two classes of biomacromolecules, proteins
or polypeptides and polynucleic acids, set the benchmark for
functional structures down to atomic scales. Thus, the use of
biomolecules is considered as an obvious step in the synthesis
and construction of next-generation nanomaterials and devices. A
whole newbranch termed bionanotechnology seeks for scientiﬁc as
well as economic breakthroughs in the development of bio-inor-
ganic nanomaterials with novel properties for computation and
nanotechnology, new methods in diagnosis and analytics or new
drugs and drug delivery systems [10,11]. While protein or poly-
nucleic acid scaffolds provide structural and chemical functions,
nanoparticles may contribute electronic, luminescent or magnetic
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nanoparticles can introduce further functionalities for recognition
and afﬁnity processes or change the solution properties. Attached
polymers change pharmacokinetic properties, mediate solubility
or can be used as the bulk material in blends, providing a matrix
for the embedded or surface-immobilized (bio-) nanoparticles
(Fig. 1).
This feature focuses on protein complexes which can be used
as valuable macromolecular building blocks for functional assem-
blies, as size-constrained reaction vessels, for the construction of
bio-(in)organic nanostructured hybrid materials and biocompat-
ible scaffolds for potential applications in bionanotechnology. Self-
assembled natural protein complexes, protein cage architectures
and particularly ferritin and some plant viruses have been exten-
sively used in the last few years as building blocks and templates
in bionanochemistry and bionanotechnology [13e15]. They are
robust assemblies and can be obtained from biological sources or
through in vitro expression and self-assembly. The combination of
protein complexes with inorganic nanoparticles has resulted in
materials with a number of interesting properties and applications
and received already considerable attention from applied research.
With increasing understanding and progress in modiﬁcation of
such systems, multifunctional systems can be constructed. Among
the plurality of biological entities which can be used in bionano-
technology, this feature presents mainly examples of Cowpea
Mosaic Viruses (CPMV), Tobacco Mosaic Virus (TMV) and ferritin.
They have been used as model systems for the development of
new compounds and as reference systems to test new (bio-)
chemical analytical techniques since decades. Their peculiar
properties make them ideal workhorses and they have routinely
been used to show a proof of principle. Additionally, Turnip Yellow
Mosaic Virus (TYMV) is presented, an icosahedral virus with
properties similar to CPMV. This serves to illustrate the applica-
bility of the concepts derived from e.g. CPMV to other similar
systems.
We aim to highlight recent developments in the area of deﬁned,
self-assembled bionanoparticles, starting with their structural
design, methods for modiﬁcation by chemical and genetic means
and ﬁnally, their use in the synthesis of novel nanomaterials. Many
different disciplines have to contribute to the development of these
nanosystems in bioengineering and biomedicine. The section on
the recent progress in the synthesis of well-deﬁned functional
polymereprotein conjugates aims to inspire new ideas for future
contributions of macromolecular chemistry to the construction of
materials derived from bio-(in)organic macromolecular building
blocks.Fig. 1. Schematic picture of a multifunctional bionanoparticle with different labels,
e.g.: antibodies that mediate cell-speciﬁc interactions; enzymes that perform catalytic
biological functions; polymers that shield and/or modify solution and pharmacokinetic
properties; ﬂuorescent dyes that allow tracking and visualizing the nanoparticle
distribution in cells or tissues. The interior of the protein cage can be used to load
nanoparticles for therapeutic (e.g. radio therapy) or diagnostic purposes (e.g. tracking
by magnetic resonance).2. Complexity and symmetry
In the last two decades groundbreaking developments in
biochemistry and microbiology led to tools for the analysis and
synthesis of polynucleic acids. Facile cloning and rapid PCR tech-
niques allow the design and high yield production of this class of
biopolymers. DNA and RNA nanotechnology have become an
established ﬁeld in science and complex architectures have been
obtained by assembling DNA and RNA functionalized materials
through primarily sticky-ends of complementary base pair
sequences.
While programmed assembly of polynucleic acid strands has
become a standard technique in bionanotechnology, the design of
self-assembling polypeptide or protein complexes is still a consid-
erable challenge [16,17]. Proteins have e unlike most synthetic
polymers e a more or less ﬁxed three-dimensional conformation
through covalent bonds or non-covalent interactions. This struc-
tural rigidity and the highly functional surface of proteins can drive
self-assembly of protein subunits in solution to oligomeric ﬁla-
mentous, cage-like or tubular structures and to regular patterns on
various surfaces and interfaces [18]. Symmetry plays an important
role in the assembly process [19]. Binding sites and functional
groups on such complexes are held at precisely deﬁned positions
and orientations. While protein crystals are rare in vivo, many
examples of symmetric protein complexes have been found and
characterized with the advance of electron microscopy and X-ray
crystallography. The helical symmetry in the protein shell of
tobacco mosaic virus and the cubic symmetry of spherical viruses
were already described in the mid 1950s and the regular geometry
and structure of many viruses is known today in great detail [20].
The quasi-equivalent assembly of protein subunits in icosahedral
virus capsids is a particularly early recognized and well investi-
gated, yet complex example of protein assembly [21,22].
The de novo design of peptides with predetermined geometric
structures requires detailed knowledge of structure-forming prin-
ciples. Analysis of the genomic pattern of known supramolecular
assemblies can help to make predictions for potentially self-
assembling proteins [23]. Short oligopeptides and simple tertiary
structures like beta-sheet forming amphiphilic peptides can be
synthesized by classical stepwise solution synthesis or chosen from
combinatorial libraries of structure-forming amino acid sequences.
Their manifold assembling capabilities were explored in detail
[24,25]. Although peptides which self-assemble to large extended
sheets, tubes or ﬁbers are nowadays well-known, novel particulate
architectures which were constructed by playing some sort of
“peptide Lego” are still rare. Exploiting geometrical principles,
a few novel self-assembled protein complexes have been con-
structed by rational design of peptide building blocks [26,27].
Padilla and co-workers and Matsuura and co-workers created
polyhedral cages through programmed self-assembly of designed
peptides [18,28]. Cloning techniques allow the expression of fusion
peptides in which different block sequences form various struc-
tures. Sugimoto reported about the construction of a protein ball-
spike supramolecule by fusing the b-helix forming gp5 protein of
the T4-bacteriophages to the cage-forming subunits of Listeria-Dps
(DNA-binding proteins from starved cells) at the corresponding
symmetry axis. The protein self-assembly leads to the formation of
a tetrahedral arrangement of the four helical spikes with the Dps
cage in the middle [29]. Such proteins can assemble to new archi-
tectures for which nature delivers the construction kit. The rational
design of the conformation of protein complexes to build novel
enzymatic and other biological complexes seems not out of reach
(Fig. 2).
Proteins can display a vast variety of functions. Enzymatic and
immunospeciﬁc reactions etc. are the natural working domain of
Fig. 2. a) Design principle for self-assembling cage or layer forming fusion protein. The formed nanostructure depends on the geometry of the linker between the symmetrical self-
assembling subunits [26]. (Reprinted from Current Opinion in Structural Biology 12, Yeates and Padilla, Designing supramolecular protein assemblies, 464e470, Copyright 2002,
with permission from Elsevier) b)ed) Realization of a ball- and spikes- protein supramolecular assembly: b) The dodecahedron cage of the ferritin-like protein Dps from Listeria
innocua along the three-fold axis with the three subunits surrounding the axis in different colours. c) Schematic drawing of the subunit and self-assembly of the b-helix domain of
bacteriophage T4 (gp5 C). d) Model of self-assembled Dps-gp5 C fusion protein which was constructed by fusion of the N-terminus of the Dps subunits (depicted in b) in red) with
the C-terminus of the gp5 C protein (depicted in c) in red) via a ﬂexible 22 residue linker at the corresponding three-fold symmetry axes. Two orientations along different symmetric
axis are shown and with examples indicated in the corresponding images from negatively stained transmission electron microscopy [29] (Sugimoto et al. Construction of a ball-and-
spike protein supramolecule. Angewandte Chemie e International Edition 2006, 45, 2725e2728. Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission.).
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inorganic substrates, a domainwhich only recently came into focus
[30e32]. Through modern biomolecular techniques, peptides with
non-natural and previously unknown functions can be selected
and identiﬁed. The display technologies are an elegant example of
evolutionary screening principles to identify substrate-speciﬁc
binding properties [33]. Many different aptamers, protein
sequences which show speciﬁc afﬁnities, have been identiﬁed by
this route [34,35]. The approach shows that the use of biomolecules
is not restricted to native conditions and natural working ﬁelds but
can be engineered for their use in hybrid structures and devices,
which is an invaluable advantage [36].
3. Bionanoparticles
Meanwhile, a number of different protein cage architectures are
known and characterized to great detail. In this section, we will
introduce some prominent examples, including icosahedral and
rod-like plant viruses and ferritin, which have all been used by
many research groups during the last decade. They are commer-
cially available or can be produced by rather simple biological
procedures. This section should give the reader who is unfamiliar
with the matter a general idea about protein cage architectures.
The robust nature and easy accessibility made cowpea mosaic
virus (CPMV) one of the best investigated viruses and most widely
used plant virus in bionanotechnology [37]. It is an isometric plant
virus with pseudo-T¼ 3 icosahedral symmetry and a diameter of
approximately 30 nm (Fig. 3a) [38]. The crystal structure is reﬁned
at 2.8A resolution [39] and the bipartite genome is fully sequenced
[40]. The 60 small capsid proteins (S, domain A) are arranged as 12
pentamers at the 5-fold axis and the 60 large ones (L, domains B
and C) as trimers at the 3-fold axis. The natural host range isrestricted to legumes. Infection leads to chlorotic mottling and
yellow mosaic pattern. Experimentally, high yields of virus can be
obtained from infected leaves of black-eyed pea plants (Vigna
unguiculata) after mechanical transmission. Typically 100 g fresh
leaves deliver 100e200 mg of virus [41,42].
Turnip yellow mosaic virus (TYMV) is the type species of the
genus Tymovirus (family Tymoviridae) [43]. Their capsid exhibits
T¼ 3 icosahedral symmetry with a diameter of approximately
30 nm. The protein shell is made up of 180 chemically identical
subunits and is specially stabilized through hydrophobic pro-
teineprotein interactions. TYMV particles show distinct and clearly
visible surface structures (Fig. 3b) [44]. There are two main sed-
imenting components, the protein shell with no or little amount of
RNA (T-component) and the capsid containing the single infectious
virus genome as (þ) ssRNA (B-component). The host range is
restricted to dicots. Chinese cabbage (Brassica campestris ssp. chi-
nensis and ssp. pekinensis) is found to be a useful host for propa-
gation from which it can be obtained in large amounts and good
yields [45]. TYMV and its crystalline assemblies have been inves-
tigated and characterized in great detail by atomic forcemicroscopy
with high resolution [46,47].
Tobacco mosaic virus (TMV) was the ﬁrst virus that was isolated
(Stanley 1935, Nobel Prize 1946) [48], and since then, TMV has been
connected with many scientiﬁc milestones in biochemistry in
general and virology in particular [49,50]. The tobacco mosaic virus
(tobamovirus; unassigned genus), is a rod-shaped virus with helical
symmetry [51]. The rigid tubes of approximately 18 nm 300 nm
have a central hollow core of 4 nm. 2100 subunits of a single coat
protein enclose the single RNA genome in form of a right-handed
helix (Fig. 3c). Distinct contacts between each subunit with three
nucleotides lead to an in vivo and in vitro self-assembly of puriﬁed
coat protein with viral RNA into infectious particles. As most
Fig. 3. Examples of bionanoparticles and their images in transmission electron microscopy (virus samples negatively stained with phosphotungstic acid). a) Cowpea mosaic virus
(CPMV): Ribbon diagram of the coat protein subunits (BC and A) and domains (A, B and C) and contour surface plot with corresponding colour coding. The axes of the icosahedral
pseudo-T3 symmetry are indicated. b) Turnip yellow mosaic virus (TYMV): Ribbon diagram of the identical coat protein subunits and domains (A, B and C) and contour surface plot
with corresponding colour coding. The axes of the icosahedral T3 symmetry are indicated. The TEM image shows the distinct surface morphology of the protein capsid. c) Tobacco
mosaic virus (TMV): Ribbon diagram of the coat protein subunit and biological molecule. The identical subunits (blue) arrange in a helical manner with distinct contacts around the
DNA (red) in the inner cavity. The black line indicates the axis of the rod. The TEM shows a high magniﬁcation insert of a lying rod and a perpendicular disc. d) Ferritin: Ribbon
diagram of the protein subunit and biological molecule. One of the 24 identical subunits is labelled in red. The symmetry axes of the rhombic dodecahedral arrangement are
indicated. The ferritin sample was not stained and only the mineral cores can be seen [20].
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the structure is resolved to 2.9A and 5A by ﬁber X-ray diffraction
[52] and electronmicroscopy [53,54], respectively. The coat protein
alone assembles into small disks and short helix structures
depending on pH, temperature and ionic strength as reviewed by
Klug [55]. The unique highly anisotropic shape and easy production
[41,56] made TMV for many years a model system of choice for
many investigations in analytics and surface science, e.g. scattering
techniques [57,58].
Ferritin represents a family of proteins with widespread biolog-
ical importance [59], however, most of the time ferritin from horse
spleen (HSF) is used. 24 protein subunits self-assemble to form
a cage with an outer diameter of approximately 12 nm and an inner
cavity of approximately 8 nm that is ﬁlledwith hydrated ferric oxide
(ferrihydrite Fe2O3 nH2O) (Fig. 3d) [60,61]. Ferritin preparations
from natural sources possess some heterogeneity, arising from
irreversibly aggregated dimers and trimers (polymeric forms) as
well as from different iron contents which can vary from a few
Fe-atoms to clusters with up to 4500 Fe-atoms. The protein shell is
usuallyheterogeneous, too, andconsists of amixture of twodifferent
subunits, termedH forheavyandL for light chain. The ratioofHandL
varies between organisms as well as between different tissueswithin an organism. Each subunit protein forms a four-helix bundle
that is arranged in 12 anti-parallel pairs to build a roughly rhombic
dodecahedron shape [62,63]. The resulting three-fold channel is
hydrophilic in nature and considered as the entrance for cations to
form the mineral core while the fourfold channel is hydrophobic in
nature. Both have a diameter of 0.3 nm. The formation of themineral
core is a catalytic multi-step process whose mechanism has been
investigated in great detail and is quite well understood [61,64,65].
The sequences of different subunit chains are known and have been
cloned and expressed in Escherichia coli to form recombinants
devoid of the natural subunit heterogeneity of ferritin [66,67]. The
subunits self-assemble in vitro to a 24-mer shell but only those
subunits incorporating the H-chain with the ferroxidase center can
be fully reconstitutedwith an iron core under native conditions [68].
4. Self-assembling protein materials in nano- and
biotechnology
4.1. Overview
The chemically well-deﬁned and monodisperse particulate
nature of biomolecules is the basis for using themas self-assembling
G. Jutz, A. Böker / Polymer 52 (2011) 211e232 215building blocks for hierarchically nanostructured materials and for
the production of bio-(in)organic nanoparticles [69]. The outer
surface of proteins and protein cages has been employed as poly-
valent scaffold similarly to dendrimers or multiple antigene
peptides. Besides site-speciﬁc chemical conjugation reactions,
biomolecules can be produced under genetic control which allows
a priori ultimate control of the chemical structure and functionality.
Such modiﬁed protein materials have been used e.g. as nanoscale
building blocks with novel functionality or as vaccines. The interior
cavity has been utilized as size-constrained reaction vessel for the
production of nanomaterials or for encapsulation of drugs and labels
for theragnostic applications in biomedicine. The self-assembling
properties can be used for the construction of ordered functional
arrays or nanowires. Fig. 4 gives a schematic categorization of ﬁelds
in which self-assembling proteins and bionanoparticles have been
used in the fabrication of hybrid materials.
4.2. Polyvalent scaffolds
Recently, the topological analogy of plant viruses to dendrimers
has been exploited in a number of organic reactions (overview [70];
selected examples [71e73]). Many researchers made use of the
unique dendrimer-like polyvalent properties of the protein capsid
for the synthesis of monodisperse and highly functional bionano-
particles. The close proximity of different labels could be shown by
ﬂuorescence resonance energy transfer (FRET) of differently
introduced ﬂuorescein and rhodamine dyes [74,75]. The advantage
of symmetric protein complexes over dendrimers is that their
structure is deﬁned and can be known with atomic resolution.
Labels can be introduced either on the assembled bionanoparticle
or on the disassembled protein subunits. Care has to be taken then
to direct the modiﬁcations to sites which are not involved into the
self-assembly process and may impede the formation of the
bionanoparticle.
A vast literature emerged from the ﬁrst report about using
cowpea mosaic virus particles as addressable nanoscale building
blocks [76]. Besides carboxylic groups [77], especially uniquely
addressable amino groups from lysine residues have been used inFig. 4. Schematic overview of different uses of bionanoparticles in bionanotechnology.conjugation reactions on the CPMV capsid’s exterior [78]. The
number of attached labels can be controlled through the excess
amount and the conjugation chemistry. Thus, e.g. FITC reacts
exclusively at one lysine amino group on the small subunit (KS38)
while up to four lysine amino groups per asymmetric unit can be
addressed with N-hydroxysuccinimidyl (NHS)-activated ﬂuores-
cein if the dye/protein subunit ratio is increased up to 2000. Under
less forcing conditions only KS38 is usually labelled. Many different
labels, e.g. dyes, polymers, quantum dots or antigens have been
introduced on the surface of CPMV using well-established chemical
crosslinking procedures which employed either direct activation or
bifunctional crosslinking agents. An exhaustive and current over-
view over the surface reactivity of CMPV is given by Steinmetz et al.
[79,80]. Limited stability of the virus in aqueous organic solvents
seems to be the only restriction for conjugation reactions (stability
for up to 50% DMSO in buffered solution at pH¼ 3e9 and room
temperature for prolonged time or at 60 C for at least an hour was
reported). Functional groups can be introduced on the virus surface
by chemical conjugation strategies or through site-directed and
insertional mutagenesis in clones. While the ﬁrst offers larger
variability of modiﬁcations the latter allows ultimate control of
composition and location. As an example, hexahistidine-metal
afﬁnity ligands have been introduced by both ways [81,82].
An extremely powerful orthogonal method for (bio-) conjuga-
tion reactions is copper-catalyzed azide-alkyne cycloaddition
(CuAAC), also descriptively called click-chemistry [83,84]. In
a unique and highly selective reaction, alkynes and azides react in
a [3þ 2] cycloaddition to form a triazol without interference from
other functional groups of biomolecules. The proper choice of the
copper catalyst and ligand greatly enhances the performance and
applicability of the reaction to various substrates and scaffolds
[71,85]. Installing the necessary azide or alkine groups on the bio-
logical scaffold can be done by conventional strategies, e.g. NHS-
activated esters or by genetic engineering with non-canonical
amino acids (see Fig. 18, 20). Click-chemistry has proven as the
currently most efﬁcient coupling strategy which allows single-site
conjugation reactions also with large macromolecules. For
example, Sen Gupta et al. managed to decorate CPMV with up to
125 alkyne-terminal side-chain glycopolymers with an average
molecular weight of 13 kg/mol [86]. Previously, the attachment of
e.g. PEG was limited to short polymer lengths and low labelling
ratios. Under forcing conditions, up to 70 NHS-activated PEG-2000
but no more than 29 PEG-5000 could be attached per virus particle.
The glycopolymer was additionally end-functionalized with a ﬂuo-
rescent dye which allowed convenient estimation of the number of
bound polymer chains after separation from excess polymer.
Another convenient feature of the click-reaction is the formation of
ﬂuorescent moieties upon formation of the triazol from non-ﬂuo-
rescent starting materials [87]. “Fluorogenic” reactions greatly
facilitate the tracking and analysis of the conjugation reactions
without further labelling or chemical quantiﬁcation reactions
[88,89].
Recently, also other plant viruses were employed as a polyvalent
scaffold, particularly turnip yellow mosaic virus (TYMV), an icosa-
hedral virus with a diameter of approximately 30 nm and a shell
composedof 180 identical subunits. Reactionswithdyes underNHS/
EDC (1-(3-dimethylaminopropyl-3-ethylcarbodiimide) hydrochlo-
ride)-activation were used to address lysine amino groups and
carboxylic groups [90]. The close proximity of orthogonal address-
able amino and carboxylic groups was shown by dual labelling with
terbium complexes as donor and Alexa-488 ﬂuorophore as acceptor
by time-resolved ﬂuoroimmuno assay (Fig. 5) [91]. TYMV worked
as a prototype protein scaffold for sensor development because
the ﬂuorophore was anchored via speciﬁc ligandereceptor (bio-
tineavidin) binding.
Fig. 5. Example for orthogonal labelling of bionanoparticles: Dual labelling of turnip yellow mosaic virus (TYMV) with an NHS-activated terbium complex ligand and biotine-amine
after activation of the surface accessible carboxylic acid groups of the virus coat protein with sulfo-NHS/EDC [91].
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because the commonly functional groups targeted for bioconjugation
are not available on the exterior protein surface of TMV. Endo and co-
workers used a genetically engineered TMV coat protein for the
conjugation of porphyrin-maleimide. Self-assembly of the modiﬁed
coat proteins to discs and rods leads to the formation of light har-
vesting arrays [92]. The same strategy was followed by Miller et al.
who installed differentﬂuorescent chromophores on the coatprotein
to achieve broad spectrum light collection with high efﬁciency [93].
The work of Schlick et al. signiﬁcantly broadened the range of
modiﬁcations [94]. They introduced themodiﬁcation of the tyrosine-
139 residue using diazonium salts; the robust protein assembly
allowed also harsh conditions. Click-chemistrywas used successfully
for modiﬁcation of the virus as well [95].
Modiﬁcation of ferritin is of special interest because it enables to
change the surface-assembling properties of the particles. Ferritin
with its unique cavity is able to house many different inorganic
materials and offers thus the chance to produce functional assem-
blies from the hybrid nanoparticles with interesting electronic,
magnetic and optical properties (see below). Ferritin particles with
reversed overall charge (‘cationic ferritin’) [96] and hydrophobic
solution properties (‘hydrophobic ferritin’) [97,98] were prepared.
Conjugating PEG-chains to the protein capsid produced ferritin that
could be stably dissolved in organic solvents [99]. Zheng et al.
functionalized ferritin with a numer of initiating sites for ATRP
polymerization and subsequently grafted oligo ethyleneglycol
methacrylate-polymer chains from the ferritin protein shell [73].
This conjugate was also shown to be soluble in dichloromethane. In
all these works, surface exposed carboxylic groups were addressed
through carbodiimide-mediated amide formation.
A major advantage of proteins is their ultimate precision
regarding composition (primary structure) as well as conformation
(secondary e structure). An elegant way to alter the amino acid
sequence and chemical structure is genetic engineering. Thus,
the expression of coat proteins and in vitro self-assembly of the
subunits allow the synthesis of non-natural virus capsids (virus-like
particles, VLP). Substitution with non-natural amino acids provides
protein complexes with novel desired functionalities at locations
with ultimate precision. Finn and co-workers demonstrated the
synthesis of virus-like particles derived fromhepatitis B virus (HBV)and bacteriophage Qb which contained azidohomoalanine and
homopropargyl glycine [100]. The VLPs could be labelled post-
translationally with dyes, linkers, metal complexes or proteins
through CuAAC (see Fig. 17). Ferritin chains were cloned and
expressed in E. coli and self-assembled readily in vitro to intact cages
[67]. The introduction of speciﬁc binding sequences is of particular
interest in bionanotechnology. Combinatorial phage display tech-
nology is a valuable tool to identify and isolate bindingmotifs on the
coat protein of bacterioviruses [33]. Libraries of random peptides as
part of the phage coat protein are screened in a few rounds of
selection for binding afﬁnity to different inorganic materials
[30,101]. Identiﬁed peptide sequences can be incorporated into the
E. coli expression vector for the ferritin subunit. Kramer et al. fused
a sequence to the C-terminus of the coat protein which binds
speciﬁcally to silver nanoparticles and directed thus the formation
of silver nanoparticles to the interior of the ferritin cage (Fig. 6)
[102]. Antigenor other sequenceswhich are fused to theN-terminus
of the subunit will be displayed on the exterior surface and yielded
functional particles for cell targeting, diagnostic purposes or afﬁnity
for inorganicmaterials [103,104]. Both insertions do not hamper the
self-assembly properties of the subunits to intact particles.
The presented plant viruses and ferritin have an intrinsic
symmetry and thus the chemical functionalities are distributed over
theparticles’ surface in a regularmanner. Chemicalmeans have to be
employed to break the symmetry. Young, Douglas and co-workers
used a solid-phase synthetic approach [105,106]. LiDps, the DNA-
binding protein from Listeria innocua, consists of 12 subunits that
self-assemble into a hollow protein cage with an outer diameter of
9 nm, was ﬁrst bound to solid-phase support particles via disulﬁde
linkages. Three out of 12 of the functional groups on the outside of
the protein cage remain unoccupied and can be labelled. Cleaving
LiDps from the support left the other nine free cysteine groups for
reaction with a second label. Unsymmetrically functionalized
particles tend to much less crosslinking phenomena than Janus-like
particles. The in vitro self-assembling properties of bionanoparticle
subunits allow also another approach, namely the mixed self-
assemblyof differently functionalized subunits. Thishas been shown
e.g. for the Cowpea chloroticmottle virus or ferritin [107,108]. Labels
can also imped the self-assembly properties. Mueller et al. show
a nice example for differently modiﬁed TMV coat proteins [109].
Fig. 6. a) Gene construction of a ferritin subunit with silver binding peptide for display
on the interior of the assembled cavity. b) Incubation of non-modiﬁed ferritin, silver
binding peptide and engineered ferritin and c) the corresponding UVeVis spectra. d)
Uranyl-stained TEM image of assembled engineered ferritin particles with silver cores.
e) High-resolution image of a silver core showing lattice fringes. Reprinted with
permission from Ref. [102]. Copyright 2004 American Chemical Society.
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synthesis
When in the beginning of the 1990s research was focusing on
the preparation of well-deﬁned nanoparticles, Mann and Meldrum
were the ﬁrst who made use of the cage structure of the iron-
storage protein ferritin as size-constrained reaction vessel [110,111].
The interest went well beyond understanding biomineralization
but was looking to use bio-nanoreactors for the production and
encapsulation of non-native technologically relevant inorganic
materials.
Ferritin became the prototype of a bio-inorganic composite
nanoparticle [15]. Since then, numerous different inorganic cores
have been synthesized inside the capsid, e.g. semiconductor
nanoparticles of CdS [112], CdSe [113], ZnSe [114] and PbS [115] or
metallic nanoparticles of Pd [116] and Ag [117] and many more but
to name a few (Fig. 8). Various ﬁelds of applications have been
demonstrated for these bio-inorganic particles in parallel [118,119].
Two approaches have been mainly followed for the templated
nanoparticle synthesis: Either reassembly of the protein cage from
the subunits in presence of the material which should be encap-
sulated or incubation of the empty and intact apoferritin with the
respective metal ions, followed by conditions inducing slowly themineral precipitation (Fig. 7). The accessibility of the interior is
restricted by the size of the hydrophilic channels in the protein
cage. The directed mineralization inside the capsid is prerequisite
for the controlled synthesis of nanoscale materials without non-
speciﬁc bulk precipitation. In vivo, the formation of the ferrihydrite
core is enzymatically controlled through the ferroxidase site at the
interior protein surface. For non-ferroxidase substrates or for
mineralization in virus capsids which is not assisted by speciﬁc
proteins, the spatial selectivity is controlled by charged nucleation
sites at the protein interface. Previously unknown ferritins from
life-forms in extreme conditions, e.g. the hyperthermophile Pyro-
coccus furiosus, allow expanding the synthetic conditions for
preparation of hybrid materials e.g. to high temperatures [120]. An
expanded temperature range can be of importance when nano-
particles with different crystalline phases and e.g. better magnetic
properties are desired.
Only the maximum loading of the protein cage gives a good
uniform size distribution of the formed nanoparticles and thus, the
interior dimensions of the protein cage dictate the ﬁnal size of the
core. Other ferritin cages with smaller cavity sizes have to be
chosen for the bio-templated preparation of smaller inorganic
nanoparticles. For example, the 5 nm cavity of the dodecameric
bacterioferritin from L. innocua shares structural features with
ferroxidase sites [121]. Cobalt oxide nanoparticles or ultrasmall
platinum clusters were successfully prepared [122,123].
The approach was also expanded to plant viruses and many
other protein cage systems, e.g. heat shock proteins [118,124,125].
4.4. Bionanoparticles as scaffolds and templates for materials
synthesis
Viruses can serve as building blocks or can be used themselves
as scaffolds for the fabrication of novel bio-(in-)organic nanoscale
and nanostructured materials [124]. Of particular interest are one-
dimensional conducting nanostructures that can be used to build
nanoelectronic devices. Phospholipid tubes or microtubules are
classical templates for ﬁlamental or rod-like structures [126].
However, both suffer from limited stability because they are non-
covalent assemblies and sensitive to solution conditions. The highly
functional, negatively charged DNA has been routinely utilized for
decoration with nanoparticles or deposition of conducting metal
layers [127]. Polypeptides which form preferably highly stable
structures like b-sheets can also form considerably stable ﬁbers
which provide a robust and highly functional template for metal-
lization [128,129].
TheM13 bacteriophage has a ﬁlamentous shapewith a length of
over 800 nm. The coat proteins are very amenable to changes via
genetic engineering. Particularly, the easy genetic manipulation
enabled the development of the above mentioned phage display
technology. With this technology, speciﬁc binding sequences of
inserted peptide libraries on the virus protein coat can be identiﬁed.
Thus, it was an evident step to engineer phages and produce bio-
inorganic hybrid assemblies. Insertion and expression of speciﬁc
binding sequences can be achieved either for the coat protein only at
the ends or along the whole virus capsid [130,131]. Annealing of the
phageswith ZnS or CdS nanocrystals aligned along the virus yielded
long single crystalline semiconductor nanowires [132]. The two-
dimensional assembly of the phages on electrostatically cohesive
ﬁlms of polyelectrolytes onmacroscopic length scales represents an
interesting approach for novel nanostructured and functionalized
polymer surfaces for sensor or battery applications [131,133].
The rod-like tobacco mosaic viruses (TMV) have the additional
advantage of being rigid and shape persistent. Thus, TMV is an
attractive template and utilized in wild-type or genetically engi-
neered form in a number of approaches to synthesize nanowires
Fig. 7. Ferritin for the template synthesis of inorganic nanoparticles. a) Ferritin as nanoreactor. b) Synthesis of nanoparticles by the disassembly/reassembly route. Removal of excess
salt by dialysis or gel ﬁltration is optional as the ferritin cavity provides for some reactions a speciﬁc reaction environment over the surrounding.
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rods which were homogeneously and densely coated with e.g.
gold nanoparticles or platinum clusters [135,136]. However, the
conductivity of such rods is poor because the single nanoparticles
are electrically isolated. Royston et al. introduced a procedure in
which they stabilized the TMV template with a thin silica shell
before metal deposition. Polyaniline-coated TMV was sufﬁciently
stable to withstand harsh Stöber conditions. TMV-silica composite
rods were then successfully coated in silver, gold, palladium or
platinum salt solution upon reduction with dimethylaminoborane
[137]. In another similar approach, conducting poly(styrenesulfo-
nate)-doped TMV-poly(aniline) ﬁbers were coated with in solegel
process with titania [138]. Such ﬁbers could ﬁnd application in
nano-sensor devices because they combine inherent conductivity
with a nanoscale catalytic surface. TMV with an additional inserted
cysteine in the coat protein could readily be metalized with nickelFig. 8. Ferritin templated synthesis of nanoparticles. a) TEM image of CdSe nano-
particles formed in apoferritin. The insert shows a high-resolution image of a single
CdSe nanodot. b) Size distribution of CdSe cores obtained from TEM. c) A gallery of
various semiconductor/ferritin bionanodots. Dps from Listeria yields smaller particles.
All images were stained with aurothioglucose [118]. Reproduced by permission of The
Royal Chemical Society.or cobalt through an electrodeless plating procedure [139]. Inter-
estingly, if the reaction were done in the presence of gold-coated
silicon substrates, the virus would have ordered perpendicular to
the surface. Such assemblies had a very high surface area and could
be suitable for the fabrication of microbatteries [140,141].
TMV was also used as template for the preparation of organic
conducting nanoﬁbers (Fig. 9). In a typical synthesis, aniline was
oxidatively polymerized at room temperature in aqueous solutions
of TMV [142e145]. At near neutral pH-values, long ﬁbers with few
ten micrometers in length and 21 nm in diameter (measured by
TEM) were formed through the head-to-tail self-assembly capa-
bilities of TMV. The assembly process was further enhanced by the
surface polymerization of aniline. The electrostatic interaction of
aniline/polyanilinewith the negatively charged coat protein surface
restricted the polymerization reaction exclusively to the virus
surface. Bruckman et al. investigated the formation of ﬁbers after
functionalization of TMV [143]. The uncharged coating prevented
interaction with aniline and no surface polymerization was
observed. However, introducing sulphate groups on the tyrosine
moieties of the subunits increased interaction and prevented the
formation of long ﬁbers because head-to-tail assembly was
hindered. In contrast, ammonium thiophene could be polymerized
successfully in presence of unmodiﬁed TMV at near neutral pH,
similarly like aniline. The reaction pH inﬂuenced themorphology of
the ﬁnal product as well: Only single tobacco mosaic viruses could
be observed at low pH< 2.5. At intermediate acidic pH¼ 4, initially
formed single composite ﬁbers tended to aggregate during the
course of the reaction to form ﬁber bundles. Long and well
dispersed single ﬁbers were obtained only at near neutral pH [145].
The non-conducting ﬁbers of branched polyaniline which formed
at near neutral pH could be converted to conducting and well
water-soluble ﬁberswhen aniline is polymerized in a second step at
low pH in presence of polystyrenesulfonate [142].4.5. Surface patterning with self-assembled bionanoparticles
4.5.1. Decoration of solid surfaces with bionanoparticles
The monodisperse nature of proteins and bionanoparticles
makes them readily crystallizing in regular patterns on surfaces
[146,147]. The adsorption and manipulation of two-dimensional
arrays of ferritin on various surfaces and interfaces has been
investigated intensively and in great detail [148e150]. Bacterial
surface layers (termed S-layers) are a prominent example of
ordered two-dimensional arrays of proteins at interfaces [151,152].
The protein sheets exhibit almost pure crystalline symmetry and
are oriented with a different top and bottom side.
Fig. 9. Synthesis and TEM images of a)ec) short PSS/PANi/TMV rods (pH¼ 5 non-
conducting; pH¼ 4 conducting) and of d)ee) long ﬁbers PANi/TMV (non-conducting)
and PSS/PANi/TMV (conducting). f) UVeVis spectra of native TMV and the polymer/
TMV composite rods and ﬁbers. The three absorption peaks atw420, 320 and 825 nm
indicate the formation of conducting emeraldine salt form of PANi. Adapted in part
with permission from Ref. [142]. Copyright 2007 American Chemical Society.
Fig. 10. Unstained TEM image of ferritin array on carbon ﬁlm. The ferritin array was
transferred from the watereair interface to a holey carbon grid and reinforced by
carbon coating. Reprinted with permission from Ref. [154]. Copyright 2006 American
Chemical Society.
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interfaces depends critically on solution conditions and the pres-
ence of e.g. cadmium ions or adsorptive layers, either formed
through initially spread proteins, charged polypeptides or surfac-
tants. After pick-up on a hydrophobically coated silicon wafer,
2D-crystalline ferritin arrays could be thermally treated to removethe protein shell and ﬁx the iron-oxide core on the substrate [149].
The possibility to ﬁll the ferritin cavity with different inorganic
materials makes it a versatile platform for nanoparticle arrays.
Although the formation of 2D-crystalline arrays is experimentally
still a delicate task, Yoshimura and co-workers have managed to
produce excellent arrays of ferritin and Dps loaded with inorganic
minerals over large areas (Fig. 10) [153,154]. Unfortunately, the
experimental difﬁculty of this procedure makes the fabrication of
arrays by this method unsuitable for robust device production. The
surface crystal growth from a three-phase contact line has been
proposed by Ikezoe et al. as an appealing simple method to prepare
very large scale, well ordered and dens two-dimensional assemblies
[155]. Selective nanoscale positioning of ferritin was realized by
target-speciﬁc peptides that had been fused to the surface exposed
N-terminus. Such modiﬁed ferritins bind with good selectivity to
the respective inorganic surface and thus allow the formation
of nanodot-arrays on arbitrarily lithographically pre-structured
surfaces [156]. A printing method based on lithography controlled
dewetting has been used to produce single lines of assembled
ferritins [157]. Strong covalent binding yields dense but usually
irregular assemblies. For example, gold surfaces were activated
towards amide bond formation by a self-assembled layer of disul-
ﬁdes, carrying a succinimidyl moiety. Ferritin formed irregular
assemblieswith occasional formationof aggregateson such surfaces
[158]. The same was observed when ferritin was thiolated with
2-iminothiolane hydrochloride and covalently immobilized on
gold surfaces [159]. Electrostatic adsorption of ferritin can be ach-
ieved with appropriately chosen surface potential and ferritin
particle charge. The electrostatic interaction potential can be
adjusted through the buffer strength, thus varying theDebye length,
i.e. the distance over which electrostatic interactions are greatly
attenuated. Calculation of the spatial distribution of the total
interaction free energy was performed for regular 15 nm disc
pattern of 3-aminopropyltriethoxysilane (APTES) on a siliconwafer
[160]. Single ferritin particles could be deposited on the APTES
islands under optimized electrostatic conditions. Such selectively
deposited nanodots can be part of a more sophisticated nano-
electronic system. For example, the mineral cores can work as
catalyst for carbon nanotube growth [161]. For applications in
nanoelectronics where irregular quantum dot arrays are sufﬁcient,
simple droplet evaporation methods, convective assembly or spin-
coating on polyelectrolyte layers can be done. They yield dense
arrays without crystalline order [162e164].
Fig. 11. a) Confocal laser scanning microscopy of a perﬂuorooctane-in-water emulsion,
stabilized by ﬂuorescein-tagged CPMV. b) AFM image of a CPMV stabilized poly
(dimethyl siloxane, PDMS) surface after UV-crosslinking. c) AFM image of a TMV
stabilized PDMS surface after UV-crosslinking. d), e) SEM image of the sample in c).
Black lines should guide the eye.
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ieved through electrostatic adsorption [165], covalent immobiliza-
tion [166e168] or speciﬁc binding. Covalent immobilization yields
usually irregular multilayers due to strong and irreversible virus-
substrate and interviral interactions [166]. The formation of such
assemblies thus depends onvirus concentration, solution conditions
and additives like PEG [167] Chemo-selective binding to line
patterns on a substratewas achieved bynickel-mediated interaction
between the nitrilotriacetic acid-functionalized substrate and the
genetically modiﬁed CPMV to present a hexahistidine tag on its
capsid [169]. Soft polymer surfaces led to denser and more regular
patterns than hard surfaces.
Virus layers with their inherent immunological properties and
multifunctional surface were considered as building blocks for the
construction of diagnostic arrays. For example, Steinmetz et al.
investigated the formation of CPMV-multilayer arrays on solid
supportsviabiospeciﬁc recognition.Biotin-functionalizedCPMVwas
dual labelledwithﬂuorescentdyesand immobilizedonstreptavidin-
functionalized surfaces. The layer formation was monitored by
quartz crystal microbalance or ﬂuorescence microscopy [170,171].
The adsorption of non-modiﬁed plant viruses and proteins on
surfaces in aqueous buffered solution is mainly governed by elec-
trostatic interactions. The formation of virus layers depends there-
fore on the isoelectric point (pI) and the surface chargeof theparticle.
At solution conditions below pI, viruses should adsorb strongly to
negatively charged surfaces and weakly on positively charged
surfaces; for solution conditions above pI the reverse should hold
true. The largest amount of virus can be deposited at the pI itself
because there is the balance between the opposing trends of parti-
cleesubstrate attraction and particleeparticle-repulsion [172].
However, particle charge is not the only factor which governs the
layer-by-layer assembly of virus capsids and polyelectrolytes. Stein-
metz et al. observed different architectures for spherical and rod-like
viruses in multilayer assemblies. While icosahedral CPMV was
readily incorporated into multilayers in the expected alternating
manner, rod-likeTMVwasﬂoatingatopof thepolyelectrolyte surface
with spontaneous ordering [173]. A similar effect was also observed
earlier for ﬁlamental bacteriophages [133].
The formation of one-dimensional structures is of special interest
for the construction of nanowires and other structures in nano-
electronics. Thus, the controlled deposition and alignment of
conductive wires from TMV is a topic of current investigations. For
example, Velev and co-workers reported the formation of conduct-
ing ﬁbers from ﬂow-aligned tobacco mosaic viruses and covalently
attached gold nanoparticles [174]. Silver enhancement was applied
to ﬁnally achieve a continuous conducting metal layer. Micrometers
long, end-to-end assembled TMV with single-virus width were
printed on adhering surfaces from structured hydrophilic PDMS
stamps andwould formviable templates for the preparation of virus
nanowires after metallization [175]. Complex patterns on a single-
particle level were generated on carboxylic acid functional surfaces
by metal-ion mediated selective adsorption. AFM-based dip-pen
lithographywasused togenerate thechemical pattern for theprecise
and oriented deposition of single TMV [176]. Previously, the ﬁrst
report on TMV assemblies perpendicular to the surface was pub-
lished [139]. A TMVmutantwas created by insertion of an additional
cysteine at theamino terminusof the coat protein. Since this cysteine
is only sufﬁciently exposed at the end of the viruswhich contains the
30 endof thegenomesequence, preferredvertical arrangementof the
virus rods was observed on gold surfaces.
4.5.2. Adsorption of bionanoparticles to liquid interfaces and soft
polymeric surfaces
Liquideliquid interfaces have been proposed to be “the
emerging horizon for self-assembly of nanoparticles” [177]. Solid-stabilized emulsions, known as Pickering Emulsions, and protein-
stabilized emulsions are of considerable technological importance
and have been investigated for decades. However, the ﬁeld expe-
rienced a renaissance after stimulating reports from the group of
Russell and co-workers [178,179]. Soon it was assumed that bion-
anoparticle stabilized emulsions could have interesting applica-
tions in drug delivery or as functional surfaces and interfaces. In
a pioneering report, Russell et al. described the preparation of an
emulsion of perﬂuorodecalin droplets in water which were stabi-
lized by a monolayer of CPMV viruses (Fig. 11) [180]. Detailed
investigations of the bionanoparticle covered interface showed that
the virus cage is not des-integrating upon their adsorption. Simi-
larly, TMV and TYMV were employed and the formation of the
interfacial assembly kinetically and structurally investigated
[181,182]. Particularly, the anisotropic rod-like TMV assembled
either parallel or perpendicular to the surface, depending on the
solution ionic strength or TMV concentration [181]. While model-
ling of respective surface tension curves indicated that “normal”
proteins like BSA are e at least partially e unfolded at the interface,
direct experimental results are difﬁcult to obtain and sometimes
contradictory. Bionanoparticles with their more distinct shape and
robust structure are better amenable to microscopic investigations.
Scanning force microscopy (SFM) and electron microscopy tech-
niques were applied to image the bionanoparticles assembly at the
interface of an liquid polymer precursor (poly(dimethyl siloxane),
PDMS) which could be crosslinked by UV-light. By this trick, the
equilibrium assemblies of bionanoparticles could be preserved and
investigated in detail. In Fig. 11 it can be seen that the particles form
a dense, although not regular assembly at the interface. Moreover,
TMV was not forming liquid-crystalline arrays with parallel rods.
The emulsions could be washed to remove excess nanoparticles
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the bionanoparticles are irreversibly trapped at the interface.
A detailed investigation of the TMV adsorbed at the interface
indicated that the rod was forming strongly curved bends when
crossing each other (Fig. 11). This indicates the strong attraction to
the interface but also a probable softening of the viral nucleo-
protein by surface denaturing upon contact with the oil phase. Such
thin biopolymer monolayer arrays can retain its function. For
example, Zhu andWang showed that a conjugate of b-galactosidase
with polystyrene which was able to self-assemble at the interface
had an increased stability and was active in the enzymatic inter-
facial transformation of lactose to octyl galactoside [183]. Further,
the protein covered interface forms a viable template for bio-
mineralization. Jutz and Böker used bovine serum albumin (BSA)
and ferritin to stabilize oil-in-water emulsions. After exchange of
the water phase with aqueous calcium phosphate solutions, slow
and steady growth of mineral shells was observed [184].
Bionanoparticles were also used to stabilize polymer particles
by assembling at the surface. When poly(4-vinyl pyridine) (PV4P)
in dimethyl formamide was co-dissolved in an aqueous solution of
CPMV, the bionanoparticles enabled solubilisation of the fairly
hydrophobic polymer at pH> 5. Well-deﬁned, sub-micron polymer
spheres were produced upon slow dialysis against water. The poly-
mer was becoming less soluble but the virus was assembling at the
interface and kept it from phase separation and precipitation. Upon
equilibration, a regular and dense assembly of CPMVon the polymer
colloid surface was obtained ﬁnally, much of the imagination of
a raspberry (Fig.12) [185]. It was proposed that theﬁnal productwas
thermodynamically controlled and a simple geometrical model of
the virus size and a hexagonal pattern could explain the decreasing
colloid size with increasing virus mass to polymer mass-ratio
[186]. The approach worked as well for TYMV, ferritin and rod-like
viruses like TMV and bacteriophage [185e187]. The concept can be
considered as an approach to produce responsive drug carriers. The
polymerebionanoparticle colloids can be redissolved at pH< 4,
releasing the surface trapped proteins and therapeutic or diagnostic
species which are conjugated or entrapped in the polymeric core.
Materials and surfaceswith immobilized or “imprinted”proteins
and bionanoparticles can work as viable scaffolds for chemical
selective separations, biomimetic sensors and the development of
biomedical devices andmaterials, e.g. artiﬁcial antibodies [188,189].Fig. 12. a) CPMV and b) TMV assembled at the surface of P4VP particles after dialysis of
the bionanoparticleepolymer mixture against water which lead to desolvation and
phase separation of the polymer. The process is schematically shown in c) [185].Molecular imprinting of bulk materials with large biopolymers has
faced limitations because removal of the templatingmolecules is as
difﬁcult as the later access of the large analyte molecules. Recent
developments in imprinting surfaces with protein-recognition sites
have solved this problem [190,191]. Suitable protective layers, e.g.
disaccharides and ﬂuoropolymers, mediate the bionanoparticles’
chemical and structural information to the interface and transfer the
complementary chemical functionalities and shape to the matrix.
Bionanoparticles canusuallynot directly bemixedwithpolymers
due to solvent incompatibility. Many polymers are only soluble in
organic solvents and strong polar organic solvents usually denature
proteins if not used in aqueous mixtures with a low solvent-to-
water ratio. Thus, the ﬁrst step to prepare protein or bionanoparti-
cleepolymer blends is to ﬁnd a common solvent or to modify the
bionanoparticles appropriately. Alkylated [97,98] or PEGylated
ferritin [73,99] shows good solubility in dichloromethane. TEM
conﬁrmed that the protein cage did not disassemble. Such modiﬁed
ferritin could be dissolved in polymer blends. After the initial stim-
ulating report by Russell and co-workers onlymarginal progress has
been achieved. Russell showed that the presence of nanoparticles
changes the morphology of micro-phase-separated block copoly-
mers. For example, lamella-forming poly(2-vinylpyridine)-b-poly
(ethylene glycol) changed the orientation from parallel to perpen-
dicular to the surface in presence of PEG-ferritin but the localization
of ferritin was difﬁcult [192]. In thin ﬁlms of polystyreneepoly
(ethylene oxide) block copolymers, poly(PEG methacrylate) modi-
ﬁed ferritin was directed to the cylinder phase because of the solu-
bility [193]. Wild-type and modiﬁed ferritin were also used for
phase-selective adsorption in phase-separated polymer blends
[194]. Due to itsmultifunctional surface, the ferritin protein cage can
interactwithpolymer chains andefﬁcientlymediate loadbearings to
the matrix. For example, ﬁbers from water-soluble polv(vinyl
alcohol) which have been electrospun from polymereferritin
mixtures had markedly increased toughness (Fig. 13) [195]. This is
also seen in an absolute absence of creep during pH-triggered
actuation of the nanoﬁbrous composite hydrogels [196]. The
composite hydrogels are stable in a wide range of pH-values and
applicable to magnetic resonance imaging-based detectable cell
culture scaffolds due to the superparamagnetic iron-oxide core
[197]. Acid-treated carbon nanotubes which were functionalized
with ferritin were readily dispersed in PVA matrices and the elastic
modulus increased dramatically compared to composites prepared
with pristine carbon nanotubes [198].
4.6. Synthesis of polymerebionanoparticle conjugates
Evidently, bio-(inorganic) nanoparticles exhibit interesting
propertieswhich could add valuable functions and functionalities to
various other materials, surfaces and interfaces or function as
therapeutic or diagnostic agents by themselves. Biomacromolecules
can be covalently linked to polymers, used in blends or immobilized
on functional polymeric surfaces. The covalent conjugation to
polymers and (polymeric) surfaces is particularly important modi-
ﬁcation processes to prepare proteins and protein complexes for use
in applications, as in biomedicine or as molecular sensors in diag-
nostic assays. We will focus here primarily on the preparation of
well-deﬁned site-speciﬁc conjugation reactions. Polymereprotein
hybrid materials are still a niche although they gained steeply
increasing interest in the last years. Undoubtedly, this is connected
with excellent progress in the preparation of well-deﬁned func-
tional polymers via controlled radical polymerization techniques.
Until recently, mostly water-soluble poly(ethylene glycols) (PEG)
were conjugated to proteins. A portfolio of suitably end-functional-
ized and activated PEGs of different chain lengths is commercially
available [199]. This is attributed to the change in pharmaceutical
Fig. 13. a) PVA/ferritin composite ﬁbrous hydrogel from electrospinning. b) Detail of
a ﬁber showing the dispersed ferritin particles. c) Stressestrain curve showing the
markedly increased toughening of composite ﬁbers [195]. Reprinted with permission
from Shin, Kim et al.: Appl. Phys. Lett. 93 (2008), 163902. Copyright 2008, American
Institute of Physics.
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often collectively named biologics. The modiﬁcation of macromo-
lecular biological drugs and drug delivery systems with poly
(ethylene glycol) (PEGylation) is awell-established and -investigated
method to enhance blood circulation time and stability, decrease
non-speciﬁc binding and immunogenicity etc. [200,201]. Other
polymers are rarely used for the preparation of polymereprotein
block copolymers, certainly also because of regulatory issues in the
ﬁeld of biomedicine [202,203]. However, they are considered
important for further improving the pharmacokinetic performance
of conjugates [202,204,205].
The advancements in the preparation of well-deﬁned functional
polymers, particularly the newly developed methods of controlled
radical polymerization, e.g. reversible addition fragmentation chain
transfer (RAFT) radical polymerization or atom transfer radical
polymerization (ATRP) allowconducting controlledpolymerizations
in aqueous solutions at ambient conditions [206,207]. The basic
strategy of controlled radical polymerization techniques relies on
the establishment of a large pool of dormant radicals which can be
easily reactivated and are in equilibrium with propagating species.
Most important, they tolerate the presence of a wide variety of
functional groups. Thus, these polymerization techniques are
particularly well suited for the preparation of polymereprotein
block copolymers, either bygrafting-onto or grafting-frommethods.
Grafting-onto strategies (convergent synthesis) build on the prep-
aration of deﬁned functional polymers which are conjugated to
the biopolymer via reactive groups and established crosslinking
chemistries [208]. For the grafting-from strategy (divergent
synthesis), biopolymers or biological scaffolds are suitably func-
tionalizedwith initiators or transfer agents and the polymer chain is
grown directly from the biomaterial. The different approaches have
been reviewed recently byHaddleton andKlok [209,210]. Since then,new exciting results have been reported, particularly on grafting-
from approaches under very mild conditions. Figs. 14 and 16 give
a schematic overview over polymerization reactions and functional
versatility. The table is notmeant to be exhaustive but limited to the
most recently reported progress.
End-functional polymers for grafting-onto can be synthesized by
startingwith a suitable functional initiator (optionally protected) or
bymodiﬁcation of end groups after polymerization (Figs.14 and 16).
For example, Haddleton and co-workers used a 2-bromoisobutyryl
ester with a protecting acetal as initiator for ATRP (Fig. 14). After
polymerization of poly(ethylene glycol) methacrylate (PEGMA) and
deprotection under acidic conditions, aldehyde end-functional
polymers were obtained [211]. Samanta et al. synthesized unpro-
tected benzaldehyde-functional ATRP-initiators for the preparation
of poly(methacryloyloxyethyl phosphorylcholine) (PMPC), a hydro-
philic and biocompatible zwitterionic polymer [212]. Aldehydes are
suitable for conjugation to protein-amino groups via imine-forma-
tion. A second reduction step is necessary to yield stable secondary
amines. N-hydroxysuccinimidyl (NHS) activated esters are most
popular for conjugation reactions to amino groups. However, side
reactions and decreased stability in neutral and alkaline aqueous
solution constitute major drawbacks and result in low conjugation
ratios for difﬁcult reactions i.e. with few accessible amino groups or
long polymer chains. N-hydroxysuccinimidyl esters of 2-bromo-2-
methylpropionate or 2-bromoisobutyrate were used to polymerize
PEG methacrylate or MPC [212e214]. No conjugation or only low
ratios could be achieved for conjugation of MPC with lysozyme or
interferon-a2a. Click-chemistry was considered as a suitable alter-
native because of the high stability of the involved functional
groups, their strict bio-orthogonality and exceptionally high efﬁ-
ciency (see as an example Fig.15). In themost simple case, the azide
group can be introduced through azide-bromine exchange after
polymerization with any conventional ATRP-initiator [215]. To
eliminate this step, Shi et al. used an azide-functional 2-bromoiso-
buturylester for the polymerization of tert-butyl methacrylate. The
polymer was conjugated to alkyne-functional biotin or via a dia-
lkyne linker to azide-functionalized BSA. Side-chain modiﬁcations
with glucosamine and a near infrared ﬂuorescence dye produced
multifunctional polymereprotein conjugates [216]. Glycopolymers
with an azide endgroup were prepared by Sen Gupta et al. and
conjugated to CPMV (Fig. 15) [86].
Native free cysteines which are not involved in structure-stabi-
lizing disulﬁde bridges are less abundant than amines and represent
therefore very interesting targeting sites. Popular coupling strate-
gies make use of Michael-addition of the thiol group to maleimides
or the formation of disulﬁdes. Bontempo and Maynard prepared
a pyridyl disulﬁde-functionalized bromoisobutyryl ester as initiator
for the controlled polymerization of hydroxyethyl methacrylate
[217]. Around90% of the polymers contained the disulﬁde endgroup
which were directly usable for conjugation to BSA. The non-cova-
lent, yet very stable avidinebiotin interaction was also employed
to prepare bioconjugates. Biotin-end-functional poly(N-isopropyl
acrylamide) (PNIPAm) was synthesized directly with a biotinylated
ATRP-initiator by Heredia et al. [218]. Ferritin which was covalently
functionalized with thermoresponsive PNIPAm showed reversible
aggregation to raspberry like colloids at temperatures above the
cloud point at 30 C [219].
The RAFT technique also presents possibilities for a convergent
strategy (Fig. 16). Pound et al. reported that the dithioester-
endgroup of poly(N-vinylpyrrolidone) prepared by RAFT easily
converted to an aldehyde function post-polymerization [220].
The quantitative reaction was shown by NMR, gradient polymer
elution chromatography as well as MALDI-TOF mass spectrometry.
The functional polymer reacted with lysozyme and formed a cova-
lent conjugate after reduction with sodium cyanoborohydride. The
Fig. 14. Reactive end-functional polymers for grafting-onto to biomolecules via ATRP.
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NHS-activated ester group was prepared for the synthesis of other
functional RAFT agents but not used itself for the preparation of
NHS-terminal polymers [221]. Theato and co-workers presented
the use of a pentaﬂuorophenyl active ester of a dithiobenzoic acid
chain transfer agent (CTA) for the RAFT polymerization of poly
(diethylene glycol methyl ether methacrylate) [222]. Reaction of
the active ester with thyroxin and reduction of the thiocarbonyl
moiety and subsequent reaction with a thiosulfonate derivative of
biotin yielded heterobifunctional polymers [223]. Maynard and co-
workers used the unique single free cysteine of V131C T4 lysozyme
for conjugation of maleimide-end-functional poly(PEG acrylate)
(poly(PEGA)) [224]. The endgroup was obtained from a furan-pro-
tected maleimide CTA. Conjugation with up to 50% conversion was
shown by SEC and SDS-PAGE. The same chemistry was used to
prepare hetero-telechelic poly(N-isopropyl acrylamide) (PNIPAM)
by using a biotin-functional chain transfer agent. The trithiocar-
bonate group was exchanged with the furan-protected maleimide
in a radical reaction. After deprotection, conjugation to two
different proteins, streptavidin via non-covalent binding and BSA
via its single free thiol group, was successful [225,226]. A homo-
dimeric lysine conjugate was prepared, too [227]. Previously, the
authors reported also on the RAFT synthesis of poly(PEGA) with
a pyridyl disulﬁde endgroup [228]. Deprotected SiRNA with a
50-thiol group was chosen as model compound and successful
conjugation was veriﬁed through PAGE by the shift of the bands to
higher molecular weights. Upon reduction, the conjugate band
disappeared and a band at the identical position of the original
siRNA was regained. Sumerlin and co-workers prepared an azido-functional trithiocarbonate CTA and conjugated such prepared
PNIPAM via click-chemistry to BSA whose cysteines were modiﬁed
with a maleimide-functional terminal alkyne [229]. Upon reduc-
tion of BSA, a disulﬁde bridge was reduced and, additionally to
the sulfhydryl group of the single native free cysteine, two more
cysteines were amenable to modiﬁcation. In the latter two exam-
ples the second possible functionality originates from the post-
polymerizational reduction of the thiocarbonyl group of the chain
transfer agent. Boyer et al. prepared a truly bifunctional RAFT chain
transfer agent. They modiﬁed a trithiocarbonate unsymmetrically
with an azide- and dithiopyridyl-group bearing moiety [230]. A
careful assessment of the click-reaction conditions which do not
cleave the thiocarbonate group is necessary; copper(II) sulphate,
and sodium ascorbate in water/isopropanol (1/1 v/v) proved to
be suitable. Conjugation of the hetero-telechelic PNIPAM was done
to alkyne-bearing biotin and, on the disulﬁde side, to glutathione
or BSA.
The grafting-onto-approach has intrinsic limitations. Steric
hindrance and/or low stability of the reactive functional group
during long reaction times can hamper conjugation with very long
polymer chains. Further, a distribution in the number of polymer
grafts will result from multiple attachment sites which again may
depend on the graft length. More uniform conjugates can be
obtained, if the polymer is directly synthesized with a protein-
macroinitiator (grafting-from or divergent approach). Lysine amino
groups can be smoothly modiﬁed with 2-bromoisobutyryl
bromide. The installation of a precise number of initiating sites at
the protein is the crucial step in the formation of polymereprotein
conjugates with awell-deﬁned number of attached polymer chains.
Fig. 15. Click-chemistry for grafting-from of ﬂuorescently labelled glycopolymers on a viral scaffold [86]. Reproduced by permission of The Royal Society of Chemistry.
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initiator can be used to limit the number of initiating sites. Lele and
co-workers showed that precisely deﬁned conjugates can be
obtained in the case of a single initiating site. However, increasing
the initiator to protein ratio led to a variable number of initiating
sites. This results in a variable number of polymer chains [231].
Moreover, an increased steric crowding led to lower monomer
conversion. Magnusson et al. conjugated the ATRP-initiator via
a succinimide active ester to recombinant human growth hormone.
The oligoethylene glycol spacer helped to achieve full reactionwith
free protein-amino groups and to reduce steric crowding in the
subsequent polymerization of OEGMA [232]. Le Droumaguet and
Velonia chose the unique single free cysteine Cys-34 of BSA as site
for the grafting-from polymerization of NIPAM. The macroinitiator
was prepared by conjugation of a maleimide terminal isobutyl
bromide ester. Polymerization of styrene in a suitable DMSO/water
mixture resulted in giant polystyrene-BSA amphiphiles [233]. The
group of Chilkoti achieved recently the modiﬁcation of only the
C-terminus of green ﬂuorescent protein with an ATRP-initiator and
the synthesis of well-deﬁned protein-poly(oligo(ethylene glycol)
methyl ether methacrylate) conjugates [234]. Similarly, grafting-
from polymerizations with the RAFT technique were reported. For
example, Davis and co-workers used a dithiopyridyl functional
trithiocarbonate to prepare a monofunctional BSA-macroinitiator
for the polymerization of PEGA or NIPAM while De et al. chosea maleimide-functional CTA [235,236]. Fully synthetic oligopep-
tide-RAFT agents were prepared on solid supports [237].
Particularly, for multivalent scaffolds with closely located sites,
conjugation of long polymer chains has been difﬁcult [238]. Wang
and co-workers used therefore the grafting-from approach to
decorate ferritin particles with polymer chains. The ferritin protein
cage was functionalized with bromoisobutyrate and served as
multivalent initiator for ATRP polymerization of water-soluble
PEG-240 methacrylate [73]. The number of grafts, i.e. number of
initiating sites, was not determined but experiments with similar
small reagents like bromoisobutyrate showed that all four surface
exposed lysine residues K83, K97, K104 and K143 can be labelled.
The poly(PEGMA)-ferritin conjugate was soluble but aggregated in
both, water and organic solvents. Modiﬁcation with polymers is
a valuable contribution to develop ferritin as novel drug delivery
system as it combines the great potential of ferritin-like particles
for theragnostic purposes and the advantageous pharmacokinetic
properties of PEGylated proteins.
There are few useful functional groups in peptides and proteins
which allow reactions with sufﬁcient efﬁciency. The e-amino group
of lysine is very popular because it is often surface exposed and
good accessible. The drawback is their quite high abundance which
makes selective conjugations difﬁcult. The cysteine thiol group is
more reactive but often involved in disulﬁde bridges with signiﬁ-
cant importance for the structure and must be reduced to the free
Fig. 16. Reactive end-functional polymers for grafting-onto to biomolecules via RAFT polymerization.
Fig. 17. a) Copper-catalyzed azide-alkyne cycloaddition (“click-reaction”) of homo-
azidoalanine substituted virus-like particle (bacteriophage Qb) with alkyne-functional
ﬂuorescein. b) Size-exclusion chromatography of intact, dye-labelled Qb capsids
(ﬂuorescein-absorption at 494 nm co-eluting at the elution volume of the intact capsid
at 14 ml). c) SDS-PAGE showing the band of ﬂuorescein labelled Qb-protein: UV-illu-
mination (lane E), Coomassie staining (lane F). d) SDS-PAGE of Qb-transferrin conju-
gate: lane G same as lane F; lane H showing the high molecular weight bands of the
conjugate. e) TEM image of the intact Qb-transferrin conjugates [100].
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conditions and reagents and have limited value for general conju-
gation reactions. Ultimate goal would be therefore a residue- and
site-speciﬁc functionalization strategy of arbitrary choice. The use
of non-canonical amino acids can be a solution for this [239].
Incorporation of amino acids with non-natural functional groups
can be achieved by various chemical or biological pathways. The
introduction of chemo-selective handles and functionalities which
are orthogonal to that of other amino acids in the protein is
particularly valuable. For example, virus-like particles derived from
hepatitis B virus (HBV) or bacteriophage Qb were labelled with
alkyne-derivatives of e.g. ﬂuorescein, biotin, a gadolinium complex
or transferrin by click-chemistry [100] (Fig. 20). The necessary
azido-groups on the virus capsid were engineered by reassignment
of the sense codon of methionine for an azide-bearing analog,
azidohomoalanine. Global replacement of all methionines was
achieved. As the Qb-protein does not contain any methionine
(except eventually at position 1 from bacterial expression), mutants
with methionines at the most exposed position K16 and/or at an
interior position T93 were generated. The coat protein sequences
were cloned into plasmids and expressed in methionine auxotroph
E. coli strains. The replacement did not hamper the self-assembly of
the protein subunits to intact particles which were indistinguish-
able in their physical properties from their native analogs as seen in
the TEM images. HBV was however sensitive to the introduction of
the different labels and low recovery of intact particles was
observed. The Qb-bacteriophage was much less sensitive and near-
quantitative labelling of the 180 subunits with ﬂuorescein and high
recoveries of intact particles (>70%) could be obtained. Moreover,
the conjugation of even very large proteins like the 80 kDa trans-
ferrin, an iron transport protein, was successful. Both reactions
Fig. 18. a) Designed multi-block polypeptide with a b-sheet forming sequence and
a cationic oligo-lysine block for binding of polynucleic acids. b) Schematic model of the
b-ribbon, intercalated dye and siRNA. c) TEM image of b-ribbon/GFP siRNA complexes;
scale bar 50 nm. d) Knock-down experiment performed with 40 pmol GFP siRNA in the
presence of 10% serum [247].
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the coelution of ﬂuorescein at the elution volume of the intact
particles or by SDS-PAGE (Fig. 20). Mehl and co-workers succeeded
recently in introducing a bromoisobutyramido functionalized
phenylalanine into green ﬂuorescent protein on a single site and
polymerizing oligo(ethylene oxide) monomethyl ether methacry-
late with this protein-macroinitiator in aqueous solution [240]. The
global replacement of amino acids has become a feasible approach
to proteins with non-natural amino acids. However, site-speciﬁc
replacements represent still a major challenge and overcoming it
will be a challenging next step in chemical biology.
4.7. Applications
Bio-(in)organic nanomaterials cover a wide range of potential
applications. Functional nanostructures from self-assembling bio-
active building blocks will ﬁnd use in various ﬁelds in biomedicine
[241,242]. Particularly, ﬁber forming peptide amphiphileswere used
as soft biomimetic scaffolds for tissue engineering [243,244] or asscaffolds for the mineralization and repair of critical size bone
defects [245,246]. Such molecular assemblies cannot only present
binding sequences and growth factors on their outer surface but also
function as efﬁcient drug and gene carriers if they are stabilized as
small virus-like particles. For example, Lim et al. designed a multi-
block polypeptidewhich self-assembled to smallb-ribbonﬁlaments.
Small interfering RNA (siRNA) for sequence speciﬁc post-trans-
lational gene silencing (RNA interference, RNAi) formed an inter-
polyelectrolyte complex with an oligo-lysine block which was
presented on the surface of the particles (Fig. 20) [247]. The discrete
supramolecular assemblies showed excellent transfection efﬁcien-
cies in green ﬂuorescent protein knock-down experiments with
HeLa cells.Moreover, hydrophobic dyes could be intercalatedwithin
the hydrophobic space of the b-ribbon bilayer to track the intracel-
lular distribution with confocal laser scanning microscopy. Locali-
zation of the complex in the nucleus proved that this nanomaterial
maybe apotent artiﬁcial virus for geneanddrugdelivery. Interesting
to note, amultivalent presentation of a charge-neutral carbohydrate
moiety is needed as the outermost layer. It prevents aggregation via
interparticle crosslinking upon adsorption of the siRNA and ensures
high transfection efﬁciencies. Conjugation of side-chain functional
polymers could render particles with even stronger binding efﬁ-
ciencies or improved pharmacokinetic properties.
Nowadays, biomedical nanotechnology is one of the fastest
progressing ﬁelds in nanotechnology, proposing most promising
applications yet within realistic expectations. Viruses and other
protein cages have been used in a variety of applications, like cell
targeting, gene delivery, drug encapsulation and release, vaccine
development and immune modulation. The rigid scaffold and
geometrical constraints of the bionanoparticles are of high impor-
tance for the multivalent presentation of foreign epitopes. Often,
free small peptides exhibit low immunogenicity. The presentation
as fusion peptides on a macromolecular scaffold as carrier of the
antigenic determinant can strongly stimulate immunogenic reac-
tions and enhance the production of antibodies. Such virus-like
particles (VLPs) which mimic the structure of authentic virus
particles represent a novel and promising class of vaccines
[248,249]. Plant viral systems are of particular interest as they seem
to be a safe and non-toxic platform for in vivo biomedical applica-
tions, e.g. investigated for CPMV by Singh et al. [250]. Thus, epitope-
presenting systems based on CPMV and TMV have early been
realized and investigated in detail [37,251]. Viruses displaying
heterologous proteins can be constructed by genetic engineering of
fusion proteins or by chemical conjugation. The choice of method is
determined by strong differences in immunogenic properties of
the resulting virus-like particles and not every conjugate can be
produced by gene expression [251]. Few recent examples concern
the production of carbohydrate based antitumor vaccines, based on
CPMV glycan derivatives. For example, Miermont et al. conjugated
Tn glycan analogs to CPMV capsids [252]. Tn glycan is overexpressed
on many cancer cell surfaces but is a low immunogene itself.
However, signiﬁcantly increased antibody titers were observed for
the analysed sera ofmice that have been immunizedwith the CPMV
conjugates. That points out the necessity of a highly organized
display of Tn to elicit strong immune response. The produced anti-
bodies recognized MCF-7 breast cancer cell surfaces as shown by
Fluorescent Assisted Cell Sorting (FACS) with a ﬂuorescein labelled
anti-IgG secondary antibody. In another study, Kaltgrad et al. ana-
lysed theproduction of anti-glycan antibodies in chicken induced by
CPMV-carbohydrate conjugates [253]. The binding and internali-
zation of CPMV-based virus-like particles in antigene presenting
cells like dendritic cells, macrophages and B-cells has been inves-
tigated in greater detail by Gonzales et al. [254]. VLPs can also be
utilized as vectors to express valuable recombinant enzymes or
Fig. 19. Quantum dot-based detection of autoantibodies of Type I diabetes. Epitope
presentation on a) genetically engineered multivalent ferritin particles results in much
higher sensitivity than with b) non-supramolecular probes [268].
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tive source of biomacromolecular pharmaceuticals [255].
Considering the excellent packing of polynucleic acid in viruses,
well shielded from the surrounding, protein cages render a stable,
biocompatible coating around enclosed substances or nano-
particles. Such composite core-shell particles can work as excellent
capsules for the delivery of drugs and/or carrier of labels for diag-
nostic purposes (theragnostics). For example, the comparatively
small ferritin particles present less steric hinderance in in vivo
applications than other polyvalent drug carriers and has been of
interest for nuclear magnetic resonance imaging [256]. Upon
reconstitution of recombinant human H-chain apoferritin with
(NH4)2Fe(SO4)/6 H2O and hydrogen peroxide under alkaline
conditions, crystalline iron-oxide cores of maghemite (gamma-
Fe2O3) or magnetite (Fe3O4) were obtained [257]. The magnetic
resonance relaxivities R1 and R2 increased with higher iron load-
ings and came close to the values of clinically known iron-oxide
contrast agents. As the uptake of the mineralized ferritin was
signiﬁcantly higher than the uptake of iron-oxide particles of other
contrast agents, the macrophage cells incorporated higher total
levels of iron. Gadolinium(III)-based contrast agents have been
prepared as well. Similarly, excellent and higher relaxivities than
with low molecular weight Gd-chelates were obtained [258].
Moreover, the protein shell can serve as a versatile platform for cell-
speciﬁc targeting moieties or another therapeutic agent may be co-
loaded into the protein cage. Covalently bound drugs can be
released if triggerable linkers are used. Flenniken et al. bound the
chemotherapeutic agent doxorubicin via the acid-labile hydra-
zone linker to the interior of the small heat shock protein of
Methanococcus jannaschii [259]. The multivalent presentation of
epitopes will enhance and maximize speciﬁc binding properties to
tissues and cells and thus increase drug delivery efﬁciency. Destito
et al. targeted tumor cells with folic acid derivatized cowpeamosaic
viruses [260]. The folate receptor is speciﬁcally up-regulated on
a variety of human tumor cells. The signiﬁcant uptake of wild-type
CPMV was inhibited by PEGylation; redirection to KB and HeLa
tumor cell lines was achieved by PEGefolic acid conjugates
[238,260]. Efﬁcient synthesis via click-chemistry guaranteed the
consistent synthesis of CPMV particles with varying ratios of folic
acid bearing and non-derivatized PEG-chains. Tumor cell surface
carbohydrates are another kind of potential target for immuno-
therapy. Finn and co-workers showed the preparation of virus-
glycopolymer or -glycan derivatives of CPMV [252,261,262]. Such
virus conjugates were found to bind e.g. to CD22, a receptor
speciﬁcally expressed on B-cells and B lymphoma cells which need
an effective polyvalent presentation of the respective glycan ligand
[262]. However, there are also examples where uptake does not
beneﬁt from multivalent display of epitopes [263].
The main idea was further developed to ever more complex,
multifunctional nanosystems that work at the interface of physical
and life sciences [264]. Good examples are the multifunctional
MR-theragnostics which Boyes and co-workers recently intro-
duced. The core consisted of a gadolinium-metal-organic frame-
work nanoparticle for magnetic resonance imaging. It wasmodiﬁed
with biocompatible reactive polymers carrying a ﬂuorescent tag for
cellular-scale imaging and targeting ligands like GRGDS-oligo
peptides or therapeutic agents like methotrexate, an antineoplastic
drug [265]. Cage-like bionanoparticles offer an easier platform for
such multifunctional nanosystems [70]. For example, viral behav-
iour was investigated by capsid enclosed CdSe-quantum dots in
living cells [266]. In another study, Cotlet, Swanson and co-workers
engineered the subunits of chaperonin, an 18 subunit double ring,
with an oligo-his tag to accommodate water-soluble, dihydrolipoic
acid-coated CdSeeZnO quantum dots [267]. Nanoparticles of the
appropriate size were well accommodated, forming deﬁned 1:1complexes with the protein ring. The histidine ligands were not
only responsible for an efﬁcient uptake of the nanoparticles but
also for an increased photoluminescence. The potential targeting
capabilities were shown with protein rings which had been
assembled from mixed subunits, some of them carrying a biotin
ligand.
The size uniformity of the particles and the homogeneous
conformational orientation of target-binding probes on a scaffold
are also critical for excellent detection sensitivity in bioassays. Assay
sensitivity is further strongly enhanced by themultivalent display of
epitopes and the high binding capabilities. Thus, an ferritin-based
ultrasensitive detection system for the 65 kDa glutamate decar-
boxylase (GAD65) speciﬁc autoantibody, an early marker of Type I
diabetes, was demonstrated with attomolar sensitivity [268].
Human ferritin heavy chain subunitswere genetically engineered to
present the respective epitope (H-FTN-GAD65). The bound anti-
bodies (anti-GAD65mAb) were then detected by a secondary CdSe-
quantum dot labelled antibody through photoluminescence. The
same amount of immobilized non-supramolecular antigene probes
resulted in a detection sensitivity that was at least 6 orders of
magnitude lower, which impressively points out the importance of
a homogeneous scaffold for highest assay sensitivities (Fig. 19). The
simultaneous detection of two analytes, a diabetes and hepatitis
marker, with a mixture of the respective ferritin labels suggest that
multiplexed detection techniques will be feasible. Encapsulated
materials can also be used for directﬂuorescence or electrochemical
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chemically identical shell or the assembly of the bionanoparticle
shells from differently modiﬁed subunits extend the approach to
multiplexed assays.
The unique versatility of ferritin but also other protein and viral
cages to house a variety of useful inorganic materials and the
possibility to control the surface chemistry and thus the assembling
properties, make them a versatile nanoscale platform for the
fabrication of ordered arrays for e.g. nanoelectronics [119]. Yama-
shita and co-workers were one of the ﬁrst who broke the border
between the well-separated ﬁelds of clean-room semiconductor
based nanotechnology and wet biological materials for the fabri-
cation of nanoscale electronic structures [149]. After the synthesis
of nanoparticles inside the protein cavity, self-assembly on
a surface and elimination of the protein moiety, the deposited
nanodots could be reduced and burred in a silicon-dioxide layer
(BioNanoProcess). Such assemblies worked as electron storage
nodes in ﬂoating nanodot gate memory devices (FNGM) which are
promising candidates for next-generation non-volatile memory
applications. The structure is very similar to metal-oxide semi-
conductor ﬁeld-effect transistors (MOSFET) but a nanodot array is
additionally embedded above the channel. Injected charges from
the gate electrode are stored and lead to a pronounced hysteresis ofFig. 20. a) Co3O4 nanodot array on an SiO2 surface. The nanodots were prepared in apoferr
fabricated to be a part of a MOS ﬁeld-effect transistor. The crossectional TEM shows the nan
currentegate voltage) of a control device (triangles), quasi-neutral scans (circles) and memthe drain currentegate voltage curve [270]. Fig. 20 shows the
dense, nevertheless irregular assembly of Co-ﬁlled ferritin on
a silicon substrate before device fabrication. A cross-sectional TEM
of the ﬁnal MOS-structure reveals the monolayer formation on the
substrate. During annealing of the device, partial reduction can be
achieved to provide metal nanoparticles as seen with XPS. The
observed hysteresis in the drain currentegate voltage curve indi-
cated the charge conﬁnement to the embedded nanodots. Large
charge capacity, long charge retention time and good stress resis-
tance were observed when the device was operated as non-volatile
memory [271,272].
A further useful application of self-assembled ferritin bionano-
particles is the use as masks for lithography applications in nano-
electronics. In contrast to conventional colloidal particles, ferritin
and its inorganic core exhibit absolute uniformity which is repli-
cated in the image structure. Kubota et al. deposited ferrihydrite
containing ferritin on a wafer. By etching the silicon support, they
generated 7 nm columns which replicated the exact size of the
deposited ferritin cores [274,275]. Stacked nanodisk structures
were prepared with this technique that exhibited a staircase
quantum effect. The single-electron charging effect was investi-
gated by conductive AFMmeasurements and was observed even at
room temperature [276].itin and after deposition, the protein cage was eliminated by UV. b) The assembly was
odots embedded in the MOS stacked structure. c) Typical transfer characteristics (drain
ory behaviour under þ/6 V gate voltage sweep (squares) [273].
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in a variety of research works. Metal or metal oxide ﬁlled ferritin
promotes the growth of suspended, diameter-controlled single-
walled carbon nanotubes. This enables the site-speciﬁc growth of
carbonnanotubes for advanced nanoelectronic devices fromsurface
deposited ferritin particles [161,277]. The native ferrihydrite core
efﬁciently converted toxic chromium (VI) ions to chromium (III) in
aqueous solution when irradiated with visible light [278]. Protein-
stabilized and -shielded semiconductor catalysts may represent
interesting candidates for biocompatible remediation. The small
protein cages of the small heat shock protein from Methanococcus
jannaschii and the Dps from L. innocua were mineralized with
platinum [122,279]. In model reactions the efﬁcient H2-production
was shown for certainminimumplatinum loadings. The exceptional
temperature-stability of Hsp is important for the utility of such
systems in real life applications.
5. Summary and perspectives
(Bio-) nanotechnology is at the frontier of biochemistry, polymer
chemistry and material science. Previously separate ﬁelds come
together to produce materials and build devices which combine
the best properties of all the involved materials: (Bio-) organic
functional ligands that mediate interactions with the surrounding,
work as recognition tags or render them biocompatible; polymers
that work as matrix, change solubility properties or add multiple
functional groups; and ﬁnally, chemical material science that
delivers nanoparticles with unprecedented optical, magnetic or
catalytic properties or engineers organic and inorganic compounds
to composites.Obviously, intelligent combinationof these topicswill
mark a new era of nanomaterialswithmany possible applications in
the ﬁeld of catalysis, biomedical applications as diagnostic or ther-
apeutic agents, in sensing devices or nanotechnology.
In this article, we outlined the rapidly increasing interest in and
multiple uses of self-assembling proteins, particularly protein
complexes and protein cages like ferritin, bacterioviruses and plant
viruses in bionanotechnology. Monodispersity, absolute deﬁnition
of chemical (secondary) and geometrical (tertiary/quaternary)
structure, easy and manifold possibilities for manipulation and the
inherent biological functionality are a few aspects which constitute
reasons for the strong advances in the ﬁeld.
Understanding the structure-forming principles is the primary
prerequisite for the de novo design of novel self-assembling
biomolecules. Symmetric protein cages like ferritin or plant viruses
or self-assembling peptide motifs like b-sheets are structures
which are well understood today and give principal guidelines for
the construction of complex artiﬁcial structures. Therefore, artiﬁcial
systems from novel building blocks are investigated besides natu-
rally occurring bionanoparticles as well.
Conjugation of bionanoparticles with dyes, polymers and other
ligands or decoration with nanoparticles is done by chemical
means. Speciﬁc peptide sequences with binding properties can be
inserted by genetic engineering with ultimate precision and
expressed in high yields. The self-assembled structures canwork as
reaction vessels for nanoparticle synthesis or as scaffolds for the
synthesis of nanostructured bio-inorganic composite materials.
Conjugation of polymers to proteins has recently become a topic
of strong interest. Particularly, the progress in the divergent
synthesis of deﬁned polymereprotein conjugates opens new
opportunities for the preparation of novel soft materials in which
both macromolecular blocks combine for the formation of struc-
tured and functional materials. The introduction of biological
structural motifs will allow novel polymeric architectures. On the
other hand, proteins will add novel functions into synthetic poly-
mers. Fully synthetic and soluble materials will be necessary in thefurther development of (printable) sensor chips or the construction
of responsive or triggerable drug delivery systems. Incorporation of
inorganic nanoparticles will add optical, electronic or magnetic
properties which yields ﬁnally multifunctional molecular hybrid
assemblies.
The preparation of multifunctional nanosystems like those for
new theragnostic systems which have been realized only previ-
ously, is challenging and has to make use of many of the above
mentioned principles. The progress in diagnosis and disease
treatment will strongly demand those multifunctional nano-
systems in the future. Polymer-modiﬁed, biopolymer encapsulated
inorganic nanoparticles for drug delivery and cellular level imaging
can be a solution e and yet represent only one challenge for the
further advancements in bionanotechnology.
Acknowledgement
The authors thank the SFB 481 (TP B10) and the Volkswagen-
Stiftung for ﬁnancial support.
References
[1] Grzelczak M, Vermant J, Furst EM, Liz-Marzan LM. ACS Nano 2010;4
(7):3591e605.
[2] Chowdhury D. Current Science 2009;96(7):923e32.
[3] Zhang G, Wang DY. Chemistry e An Asian Journal 2009;4(2):236e45.
[4] Rivera Gil P, Huehn D, del Mercato LL, Sasse D, Parak WJ. Pharmacological
Research 2010;62(2, Sp. Iss. SI):115e25.
[5] Engel E, Michiardi A, Navarro M, Lacroix D, Planell JA. Trends in Biotech-
nology 2008;26(1):39e47.
[6] Ansari AA, Alhoshan M, Alsalhi MS, Aldwayyan AS. Sensors 2010;10
(7):6535e81.
[7] Mu L, Sprando RL. Pharmaceutical Research 2010;27(8):1746e9.
[8] Weiss J, Takhistov P, McClements DJ. Journal of Food Science 2006;71
(9):R107e16.
[9] Sugiyama S, Ohtani T. Food Hygiene and Safety Science 2010;51(2):J201e5.
[10] Niemeyer CM, Mirkin CA. Nanobiotechnology. More concepts and applica-
tions. Weinheim: Wiley-VCH; 2007.
[11] Kumar CSSR. In: Kumar CSSR, editor. Nanotechnologies for the life sciences,
vol. 1e10. New York: Wiley-VCH; 2005e2012.
[12] Niemeyer CM. Angewandte Chemie, International Edition 2003;42
(47):5796e800.
[13] Manchester M, Steinmetz NF. Current Topics in Microbiology and Immu-
nology; 2009:327.
[14] Manchester M, Steinmetz NF. Viral nanoparticles: tools for materials science
& biomedicine. Singapore: Pan Stanford Publishing; 2010.
[15] Uchida M, Kang S, Reichhardt C, Harlen K, Douglas T. Biochimica et Bio-
physica Acta e General Subjects 2010;1800(8):834e45.
[16] Tsai CJ, Zheng J, Aleman C, Nussinov R. Trends in Biotechnology 2006;24
(10):449e54.
[17] Tsai CJ, Zheng J, Zanuy D, Haspel N, Wolfson H, Aleman C, et al. Proteins-
Structure Function and Bioinformatics 2007;68(1):1e12.
[18] Padilla JE, Colovos C, Yeates TO. Proceedings of the National Academy of
Sciences of the United States of America 2001;98(5):2217e21.
[19] Bromley EHC, Channon K, Moutevelis E, Woolfson DN. ACS Chemical Biology
2008;3(1):38e50.
[20] Carrillo-Tripp M, Shepherd CM, Borelli IA, Venkataraman S, Lander G,
Natarajan P, et al. Nucleic Acids Research 2009;37:D436e42.
[21] Johnson JE, Speir JA. Journal of Molecular Biology 1997;269(5):665e75.
[22] Sinkovits RS, Baker TS. Journal of Structural Biology 2010;170(1):109e16.
[23] Beeby M, Bobik TA, Yeates TO. Protein Science 2009;18(1):69e79.
[24] Cavalli S, Albericio F, Kros A. Chemical Society Reviews 2010;39(1):241e63.
[25] Yang YL, Khoe U, Wang XM, Horii A, Yokoi H, Zhang SG. Nano Today 2009;4
(2):193e210.
[26] Yeates TO, Padilla JE. CurrentOpinion in Structural Biology2002;12(4):464e70.
[27] Usui K, Maki T, Ito F, Suenaga A, Kidoaki S, Itoh M, et al. Protein Science
2009;18(5):960e9.
[28] Matsuura K, Murasato K, Kimizuka N. Journal of the American Chemical
Society 2005;127(29):10148e9.
[29] Sugimoto K, Kanamaru S, Iwasaki K, Arisaka F, Yamashita I. Angewandte
Chemie-International Edition 2006;45(17):2725e8.
[30] Vallee A, Humblot V, Pradier CM. Accounts of Chemical Research 2010;43
(10):1297e306.
[31] Seker UOS, Wilson B, Sahin D, Tamerler C, Sarikaya M. Biomacromolecules
2009;10(2):250e7.
[32] Slocik JM, Naik RR. Chemical Society Reviews 2010;39(9):3454e63.
[33] Pande J, Szewczyk MM, Grover AK. Biotechnology Advances 2010;28
(6):849e58.
G. Jutz, A. Böker / Polymer 52 (2011) 211e232230[34] Shiba K. Current Opinion in Biotechnology 2010;21(4):412e25.
[35] Shiba K. Chemical Society Reviews 2010;39(1):117e26.
[36] Tamerler C, Khatayevich D, Gungormus M, Kacar T, Oren EE, Hnilova M, et al.
Biopolymers 2010;94(1):78e94.
[37] Sainsbury F, Canizares MC, Lomonossoff GP. Annual Review of Phytopa-
thology 2010;48:437e55.
[38] Lomonossoff GP, Shanks M. Comoviruses (Comoviridae). In: Granoff A,
Webster RG, editors. Encyclopedia of virology, vol. 1. San Diego: Academic
Press; 1999. p. 285e91.
[39] Lin T, Chen Z, Usha R, Stauffacher CV, Dai J-B, Schmidt T, et al. Virology
1999;265(1):20e34.
[40] Goldbach R, Kammen AV. Structure, replication, and expression of the
bipartite genome of cowpea mosaic virus. In: Davies JW, editor. Molecular
plant virology, vol. 2. Boca Raton: CRC Press, Inc.; 1985. p. 83e120.
[41] Dijkstra J, Jager CPD. Practical plant virology. Berlin: Springer; 1998.
[42] Wellink J. Comovirus isolation and RNA extraction. In: Foster GD,
Taylor SC, editors. Plant virology protocols, vol. 81. Totawa: Humana
Press; 1998. p. 205e9.
[43] Gibbs A. Tymoviruses. In: Granoff A, Webster RG, editors. Encyclopedia of
virology, vol. 3. San Diego: Academic Press; 1999. p. 1850e3.
[44] Canady MA, Larson SB, Day J, McPherson A. Nature Structural Biology 1996;3
(9):771e81.
[45] Gibbs A, Mackenzie AM. Tymovirus isolation and genomic RNA extraction.
In: Foster GD, Taylor SC, editors. Plant virology protocols, vol. 81. Totawa:
Humana Press; 1998. p. 219e24.
[46] McPherson A, Kuznetsov YG, Malkin A, Plomp M. Journal of Structural
Biology 2003;142(1):32e46.
[47] Kuznetsov YG, Malkin AJ, Lucas RW, Plomp M, McPherson A. Journal of
General Virology 2001;82(9):2025e34.
[48] Stanley WM. Science 1935;81:644e5.
[49] Harrison BD, Wilson TMA. Philosophical Transactions of the Royal Society of
London, Series B: Biological Sciences 1999;354(1383):521e9.
[50] Scholthof K-BG, Shaw JG, Zaitlin M. Tobacco mosaic virus: one hundred years
of contributions to virology. St. Paul, Minnesota, USA: American Phyto-
pathological Society Press; 1999.
[51] Lewandowski DJ, Dawson WO. Tobamoviruses. In: Granoff A, Webster RG,
editors. Encyclopedia of virology, vol. 3. San Diego: Academic Press; 1999. p.
1780e3.
[52] Namba K, Pattanayek R, Stubbs G. Journal of Molecular Biology 1989;208
(2):307e25.
[53] Sachse C, Chen JZ, Coureux P-D, Stroupe ME, Faendrich M, Grigorieff N.
Journal of Molecular Biology 2007;371(3):812e35.
[54] Clare DK, Orlova EV. Journal of Structural Biology 2010;171(3):303e8.
[55] Klug A. Annual Review of Biochemistry 2010;79:1e35.
[56] Chapman SN. Tobamovirus isolation and RNA extraction. In: Foster GD,
Taylor SC, editors. Plant virology protocols, vol. 81. Totawa: Humana Press;
1998. p. 123e9.
[57] Santos NC, Castanho MARB. Biophysical Journal 1996;71(3):1641e50.
[58] Lehner D, Lindner H, Glatter O. Langmuir 2000;16(4):1689e95.
[59] Arosio P, Ingrassia R, Cavadini P. Biochimica Et Biophysica Acta-General
Subjects 2009;1790(7):589e99.
[60] ChasteenND, Harrison PM. Journal of Structural Biology 1999;126(3):182e94.
[61] Harrison PM, Arosio P. Biochimica et Biophysica Acta e Bioenergetics
1996;1275(3):161e203.
[62] Banyard SH, Stammers DK, Harrison PM. Nature 1978;271(5642):282e4.
[63] Clegg GA, Stansﬁeld RFD, Bourne PE, Harrison PM. Nature (London, United
Kingdom) 1980;288(5788):298e300.
[64] Lawson DM, Artymiuk PJ, Yewdall SJ, Smith JMA, Livingstone JC, Treffry A,
et al. Nature 1991;349(6309):541e4.
[65] Liu X, Theil EC. Accounts of Chemical Research 2005;38(3):167e75.
[66] Jaaskelainen A, Harinen R-R, Lamminmaki U, Korpimaki T, Pelliniemi LJ,
Soukka T, et al. Small 2007;3(8):1362e7.
[67] Takeda S, Ohta M, Ebina S, Nagayama K. Biochimica et Biophysica Acta e
Gene Structure and Expression 1993;1174(2):218e20.
[68] Orino K, Harada S, Natsuhori M, Takehara K, Watanabe K. BioMetals 2004;17
(2):129e34.
[69] Soto CM, Ratna BR. Current Opinion in Biotechnology 2010;21(4):426e38.
[70] Lee LA, Niu ZW, Wang Q. Nano Research 2009;2(5):349e64.
[71] Sen Gupta S, Kuzelka J, Singh P, Lewis WG, Manchester M, Finn MG. Bio-
conjugate Chemistry 2005;16(6):1572e9.
[72] Barnhill HN, Reuther R, Ferguson PL, Dreher T, Wang Q. Bioconjugate
Chemistry 2007;18(3):852e9. Ref. in there.
[73] Zeng Q , Li T, Cash B, Li S, Xie F, Wang Q. Chemical Communications
2007;14:1453e5.
[74] Raja KS, Wang Q , Finn MG. ChemBioChem 2003;4(12):1348e51.
[75] Fernandez B, Galvez N, Sanchez P, Cuesta R, Bermejo R, Dominguez-Vera JM.
Journal of Biological Inorganic Chemistry 2008;13(3):349e55.
[76] Wang Q , Lin T, Tang L, Johnson JE, Finn MG. Angewandte Chemie e Inter-
national Edition 2002;41(3):459e62.
[77] Steinmetz NF, Lomonossoff GP, Evans DJ. Langmuir 2006;22(8):3488e90.
[78] Wang Q , Kaltgrad E, Lin T, Johnson JE, Finn MG. Chemistry & Biology 2002;9
(7):805e11.
[79] Steinmetz NF. Tomorrow’s Chemistry Today; 2008:215e36.
[80] Steinmetz NF, Evans DJ. Organic & Biomolecular Chemistry 2007;5
(18):2891e902.[81] Blum AS, Soto CM, Wilson CD, Whitley JL, Moore MH, Sapsford KE, et al.
Nanotechnology 2006;17(20):5073e9.
[82] Medintz IL, Sapsford KE, Konnert JH, Chatterji A, Lin T, Johnson JE, et al.
Langmuir 2005;21(12):5501e10.
[83] Iha RK, Wooley KL, Nystrom AM, Burke DJ, Kade MJ, Hawker CJ. Chemical
Reviews 2009;109(11):5620e86.
[84] Best MD. Biochemistry 2009;48(28):6571e84.
[85] Hong V, Presolski SI, Ma C, Finn MG. Angewandte Chemie-International
Edition 2009;48(52):9879e83.
[86] Sen Gupta S, Raja KS, Kaltgrad E, Strable E, Finn MG. Chemical Communi-
cations 2005;34:4315e7.
[87] Xie F, Sivakumar K, Zeng Q, Bruckman MA, Hodges B, Wang Q. Tetrahedron
2008;64(13):2906e14.
[88] DirksAJ, Cornelissen J,NolteRJM.BioconjugateChemistry2009;20(6):1129e38.
[89] Le Droumaguet C, Wang C, Wang Q. Chemical Society Reviews 2010;39
(4):1233e9.
[90] Barnhill HN, Reuther R, Ferguson PL, Dreher T, Wang Q. Bioconjugate
Chemistry 2007;18(3):852e9.
[91] Barnhill HN, Claudel-Gillet S, Ziessel R, Charbonniere LJ, Wang Q. Journal of
the American Chemical Society 2007;129(25):7799e806.
[92] Endo M, Fujitsuka M, Majima T. Chemistry e A European Journal 2007;13
(31):8660e6.
[93] Miller RA, Presley AD, Francis MB. Journal of the American Chemical Society
2007;129(11):3104e9.
[94] Schlick TL, Ding Z, Kovacs EW, Francis MB. Journal of the American Chemical
Society 2005;127(11):3718e23.
[95] Bruckman MA, Kaur G, Lee LA, Xie F, Sepulveda J, Breitenkamp R, et al.
ChemBioChem 2008;9(4):519e23.
[96] Danon D, Goldstein L, Marikovsky Y, Skutelsky E. Journal of Ultrastructure
Research 1972;38(5e6):500e10.
[97] Wong KKW, Colfen H, Whilton NT, Douglas T, Mann S. Journal of Inorganic
Biochemistry 1999;76(3e4):187e95.
[98] Wong KKW, Whilton NT, Douglas T, Mann S, Colfen H. Chemical Commu-
nications 1998;16:1621e2.
[99] Sengonul M, Ruzicka J, Attygalle AB, Libera M. Polymer 2007;48
(13):3632e40.
[100] Strable E, Prasuhn DE, Udit AK, Brown S, Link AJ, Ngo JT, et al. Bioconjugate
Chemistry 2008;19(4):866e75.
[101] Whaley SR, English DS, Hu EL, Barbara PF, Belcher AM. Nature 2000;405
(6787):665e8.
[102] Kramer RM, Li C, Carter DC, Stone MO, Naik RR. Journal of the American
Chemical Society 2004;126(41):13282e6.
[103] Jaaskelainen A, Harinen RR, Soukka T, Lamminmaki U, Korpimilki T, Virta M.
Analytical Chemistry 2008;80(3):583e7.
[104] Sano K, Ajima K, Iwahori K, Yudasaka M, Iijima S, Yamashita I, et al. Small
2005;1(8e9):826e32.
[105] Kang S, Suci PA, Broomell CC, Iwahori K, Kobayashi M, Yamashita I, et al.
Nano Letters 2009;9(6):2360e6.
[106] Suci PA, Kang S, Young M, Douglas T. Journal of the American Chemical
Society 2009;131(26):9164.
[107] Gillitzer E, Suci P, Young M, Douglas T. Small 2006;2(8e9):962e6.
[108] Zheng B, Uenuma M, Uraoka Y, Yamashita I. Nanotechnology 2010;21
(44):445602.
[109] Mueller A, Kadri A, Jeske H, Wege C. Journal of Virological Methods 2010;166
(1e2):77e85.
[110] Mann S, Meldrum F. Advanced Materials 1991;3(6):316e8.
[111] Meldrum FC, Wade VJ, Nimmo DL, Heywood BR, Mann S. Nature (London,
United Kingdom) 1991;349(6311):684e7.
[112] Naito M, Iwahori K, Miura A, Yamane M, Yamashita I. Angewandte Chemie-
International Edition 2010;49(39):7006e9.
[113] Yamashita I, Hayashi J, Hara M. Chemistry Letters 2004;33(9):1158e9.
[114] Iwahori K, Yoshizawa K, Muraoka M, Yamashita I. Inorganic Chemistry
2005;44(18):6393e400.
[115] Hennequin B, Turyanska L, Ben T, Beltran AM, Molina SI, Li M, et al. Advanced
Materials 2008;20(19):3592.
[116] Ueno T, Suzuki M, Goto T, Matsumoto T, Nagayama K, Watanabe Y. Ange-
wandte Chemie e International Edition 2004;43(19):2527e30.
[117] Dominguez-Vera JM,GalvezN, Sanchez P,MotaAJ, Trasobares S, Hernandez JC,
et al. European Journal of Inorganic Chemistry 2007;30:4823e6.
[118] Yamashita I. Journal of Materials Chemistry 2008;18(32):3813e20.
[119] Yamashita I, Iwahori K, Kumagai S. Biochimica et Biophysica Acta
2010;1800:846e57.
[120] Parker MJ, Allen MA, Ramsay B, Klem MT, Young M, Douglas T. Chemistry of
Materials 2008;20(4):1541e7.
[121] Haikarainen T, Papageorgiou AC. Cellular and Molecular Life Sciences
2010;67(3):341e51.
[122] Kang S, Lucon J, Varpness ZB, Liepold L, Uchida M, Willits D, et al. Ange-
wandte Chemie-International Edition 2008;47(41):7845e8.
[123] Resnick DA, Gilmore K, Idzerda YU, Klem MT, Allen M, Douglas T, et al.
Journal of Applied Physics 2006;99(8).
[124] Behrens SS. Journal of Materials Chemistry 2008;18(32):3788e98.
[125] de la Escosura A, Nolte RJM, Cornelissen J. Journal of Materials Chemistry
2009;19(16):2274e8.
[126] Diner BA, Harmer MA, Mitchell G. Metalization of microtubules by reducing
metal salts. Application. US USA; 2004. 17 pp.
G. Jutz, A. Böker / Polymer 52 (2011) 211e232 231[127] Pruneanu S, Olenic L, Al-Said SAF, Borodi G, Houlton A, Horrocks BR. Journal
of Materials Science 2010;45(12):3151e9.
[128] Scheibel T, Parthasarathy R, Sawicki G, Lin X-M, Jaeger H, Lindquist SL.
Proceedings of the National Academy of Sciences of the United States of
America 2003;100(8):4527e32.
[129] Ghadiri MR, Granja JR, Milligan RA, McRee DE, Khazanovich N. Nature
1993;366(6453):324e7.
[130] Lee S-W, Mao C, Flynn CE, Belcher AM. Science 2002;296(5569):892e5.
[131] Nam KT, Kim D-W, Yoo PJ, Chiang C-Y, Meethong N, Hammond PT, et al.
Science 2006;312(5775):885e8.
[132] Mao C, Solis DJ, Reiss BD, Kottmann ST, Sweeney RY, Hayhurst A, et al.
Science 2004;303(5655):213e7.
[133] Yoo PJ, Nam KT, Qi J, Lee S-K, Park J, Belcher AM, et al. Nature Materials
2006;5(3):234e40.
[134] Shenton W, Douglas T, Young M, Stubbs G, Mann S. Advanced Materials
1999;11(3):253e6.
[135] Bromley KM, Patil AJ, Perriman AW, Stubbs G, Mann S. Journal of Materials
Chemistry 2008;18(40):4796e801.
[136] Gorzny ML, Walton AS, Evans SD. Advanced Functional Materials 2010;20
(8):1295e300.
[137] Royston ES, Brown AD, Harris MT, Culver JN. Journal of Colloid and Interface
Science 2009;332(2):402e7.
[138] Rong JH, Oberbeck F, Wang XN, Li XD, Oxsher J, Niu ZW, et al. Journal of
Materials Chemistry 2009;19(18):2841e5.
[139] Royston E, Ghosh A, Koﬁnas P, Harris MT, Culver JN. Langmuir 2008;24
(3):906e12.
[140] Gerasopoulos K, McCarthy M, Royston E, Culver JN, Ghodssi R. Journal of
Micromechanics and Microengineering 2008;18(10).
[141] Chen XL, Gerasopoulos K, Guo JC, Brown A, Wang CS, Ghodssi R, et al. ACS
Nano 2010;4(9):5366e72.
[142] Niu Z, Liu J, Lee LA, Bruckman MA, Zhao D, Koley G, et al. Nano Letters 2007;
7(12):3729e33.
[143] Bruckman MA, Niu Z, Li S, Lee LA, Varazo K, Nelson TL, et al. Nano-
Biotechnology 2007;3(1):31e9.
[144] Niu Z, Bruckman M, Kotakadi VS, He J, Emrick T, Russell TP, et al. Chemical
Communications 2006;28:3019e21.
[145] Niu Z, Bruckman MA, Li S, Lee LA, Lee B, Pingali SV, et al. Langmuir 2007;23
(12):6719e24.
[146] Lorber B, Adrian M, Witz J, Erhardt M, Harris JR. Micron 2008;39(4):431e46.
[147] Aoyama K, Ogawa K, Kimura Y, Fujiyoshi Y. Ultramicroscopy 1995;57
(4):345e54.
[148] Matsui T, Matsukawa N, Iwahori K, Sano KI, Shiba K, Yamashita I. Langmuir
2007;23(4):1615e8.
[149] Yamashita I. Thin Solid Films 2001;393(1,2):12e8.
[150] Yoshimura H. Advances in Biophysics 1997;34:93e107. Protein Array: An
Alternative Biomolecular System.
[151] Schuster B, Pum D, Sleytr UB. Biointerphases 2009;3(2).
[152] Tang J, Badelt-Lichtblau H, Ebner A, Preiner J, Kraxberger B, Gruber HJ, et al.
Chemphyschem 2008;9(16):2317e20.
[153] Okuda M, Kobayashi Y, Suzuki K, Sonoda K, Kondoh T, Wagawa A, et al. Nano
Letters 2005;5(5):991e3.
[154] Yoshimura H. Colloids and Surfaces, A: Physicochemical and Engineering
Aspects 2006;282e283:464e71.
[155] Ikezoe Y, Kumashiro Y, Tamada K, Matsui T, Yamashita I, Shiba K, et al.
Langmuir 2008;24(22):12836e41.
[156] Yamashita K, Kirimura H, Okuda M, Nishio K, Sano KI, Shiba K, et al. Small
2006;2(10):1148e52.
[157] Martinez RV, Martinez J, Chiesa M, Garcia R, Coronado E, Pinilla-
Cienfuegos E, et al. Advanced Materials 2010;22(5):588.
[158] Dominguez-Vera J, Welte L, Galvez N, Fernandez B, Gomez-Herrero J,
Zamora F. Nanotechnology 2008;19(2). 025302/025301-025302/025303.
[159] Won K, Park MJ, Yoon HH, Kim JH. Ultramicroscopy 2008;108
(10):1342e7.
[160] Yoshii S, Kumagai S, Nishio K, Kadotani A, Yamashita I. Applied Physics
Letters 2009;95(13).
[161] Kumagai S, Ono T, Yoshii S, Kadotani A, Tsukamoto R, Nishio K, et al. Applied
Physics Express 2010;3(1).
[162] Kwon M, Choi H, Chang M, Jo M, Jung S-J, Hwang H. Applied Physics Letters
2007;90(19). 193512/193511-193512/193513.
[163] Miura A, Uraoka Y, Fuyuki T, Kumagai S, Yoshii S, Matsukawa N, et al. Surface
Science 2007;601(15):L81e5.
[164] Yamada K, Yoshii S, Kumagai S, Fujiwara I, Nishio K, Okuda M, et al. Japanese
Journal of Applied Physics, Part 1: Regular Papers, Brief Communications &
Review Papers 2006;45(5A):4259e64.
[165] Suci PA, Klem MT, Douglas T, Young M. Langmuir 2005;21(19):8686e93.
[166] Klem MT, Willits D, Young M, Douglas T. Journal of the American Chemical
Society 2003;125(36):10806e7.
[167] Cheung CL, Camarero JA, Woods BW, Lin T, Johnson JE, De Yoreo JJ. Journal of
the American Chemical Society 2003;125(23):6848e9.
[168] Smith JC, Lee K-B, Wang Q, Finn MG, Johnson JE, Mrksich M, et al. Nano
Letters 2003;3(7):883e6.
[169] Cheung CL, Chung S-W, Chatterji A, Lin T, Johnson JE, Hok S, et al. Journal of
the American Chemical Society 2006;128(33):10801e7.
[170] Steinmetz NF, Bock E, Richter RP, Spatz JP, Lomonossoff GP, Evans DJ. Bio-
macromolecules 2008;9(2):456e62.[171] Steinmetz NF, Calder G, Lomonossoff GP, Evans DJ. Langmuir 2006;22
(24):10032e7.
[172] Lin Y, Su Z, Niu Z, Li S, Kaur G, Lee LA, et al. Acta Biomaterialia 2008;4
(4):838e43.
[173] Steinmetz NF, Findlay KC, Noel TR, Parker R, Lomonossoff GP, Evans DJ.
ChemBioChem 2008;9(10):1662e70.
[174] Kuncicky DM, Naik RR, Velev OD. Small 2006;2(12):1462e6.
[175] Horn A, Hiltl S, Fery A, Boker A. Small 2010;6(19):2122e5.
[176] Vega RA, Maspoch D, Salaita K, Mirkin CA. Angewandte Chemie e Interna-
tional Edition 2005;44(37):6013e5.
[177] Wang D, Duan H, Moehwald H. Soft Matter 2005;1(6):412e6.
[178] Lin Y, Skaff H, Boker A, Dinsmore AD, Emrick T, Russell TP. Journal of the
American Chemical Society 2003;125(42):12690e1.
[179] Lin Y, Skaff H, Emrick T, Dinsmore AD, Russell TP. Science 2003;299
(5604):226e9.
[180] Russell JT, Lin Y, Böker A, Su L, Carl P, Zettl H, et al. Angewandte Chemie e
International Edition 2005;44(16):2420e6.
[181] He JB, Niu ZW, Tangirala R, Wan JY, Wei XY, Kaur G, et al. Langmuir 2009;25
(9):4979e87.
[182] Kaur G, He JB, Xu J, Pingali SV, Jutz G, Böker A, et al. Langmuir 2009;25
(9):5168e76.
[183] Zhu GY, Wang P. Journal of the American Chemical Society 2004;126
(36):11132e3.
[184] Jutz G, Boker A. Journal of Materials Chemistry 2010;20(21):4299e304.
[185] Li T, Niu ZW, Emrick T, Russell TR, Wang Q. Small 2008;4(10):1624e9.
[186] Li T, Ye B, Niu ZW, Thompson P, Seifert S, Lee B, et al. Chemistry of Materials
2009;21(6):1046e50.
[187] Li T, Wu LY, Suthiwangcharoen N, Bruckman MA, Cash D, Hudson JS, et al.
Chemical Communications 2009;20:2869e71.
[188] Birnbaumer GM, Lieberzeit PA, Richter L, Schirhagl R, Milnera M, Dickert FL,
et al. Lab on a Chip 2009;9(24):3549e56.
[189] Turiel E, Martin-Esteban A. Analytica Chimica Acta 2010;668(2):87e99.
[190] Shi HQ, Tsai WB, Garrison MD, Ferrari S, Ratner BD. Nature 1999;398
(6728):593e7.
[191] Turner NW, Jeans CW, Brain KR, Allender CJ, Hlady V, Britt DW. Biotech-
nology Progress 2006;22(6):1474e89.
[192] Lin Y, Böker A, He J, Sill K, Xiang H, Abetz C, et al. Nature 2005;434
(7029):55e9.
[193] Hu Y, Samanta D, Parelkar SS, Hong SW, Wang Q, Russel TP, et al. Advanced
Functional Materials 2010;20:3603e12.
[194] Sengonul M, Sousa A, Libera M. Colloids and Surfaces B-Biointerfaces
2009;73(1):152e5.
[195] Shin MK, Kim SI, Kim SJ, Kim BJ, So I, Kozlov ME, et al. Applied Physics Letters
2008;93(16).
[196] Shin MK, Spinks GM, Shin SR, Kim SI, Kim SJ. Advanced Materials 2009;21
(17):1712e5.
[197] Shin MK, Kim SI, Kim SJ, Park SY, Hyun YH, Lee Y, et al. Langmuir 2008;24
(21):12107e11.
[198] Bhattacharyya S, Sinturel C, Salvetat JP, Saboungi ML. Applied Physics Letters
2005;86(11).
[199] Pasut G, Veronese FM. Progress in Polymer Science 2007;32:933e61.
[200] Jain A, Jain SK. Critical Reviews in Therapeutic Drug Carrier Systems 2008;25
(5):403e47.
[201] Pasut G, Veronese FM. AdvancedDrugDeliveryReviews 2009;61(13):1177e88.
[202] Vicent MJ, Dieudonne L, Carbajo RJ, Pineda-Lucena A. Expert Opinion on
Drug Delivery 2008;5(5):593e614.
[203] Gaspar R, Duncan R. Advanced Drug Delivery Reviews 2009;61(13):1220e31.
[204] Vicent MJ, Duncan R. Trends in Biotechnology 2006;24(1):39e47.
[205] Liechty WB, Kryscio DR, Slaughter BV, Peppas NA. Annual Review of
Chemical and Biomolecular Engineering 2010;1(1):149e73.
[206] Millard P, Mougin N, Böker A, Müller AHE. Controlling the fast ATRP of N-
isopropylacrylamide in water. In: Matyjaszewski K, editor. Controlled/living
radical polymerization: progress in ATRP. Washington, D.C.: American
Chemical Society; 2009. p. 127e39.
[207] Boyer C, Bulmus V, Davis TP, Ladmiral V, Liu JQ, Perrier S. Chemical Reviews
2009;109(11):5402e36.
[208] Hermanson GT. Bioconjugate techniques. San Diego: Academic Press; 1996.
[209] Gauthier MA, Klok H-A. Chemical Communications 2008;23:2591e611.
[210] Nicolas J, Mantovani G, Haddleton DM. Macromolecular Rapid Communi-
cations 2007;28(10):1083e111.
[211] Tao L, Mantovani G, Lecolley F, Haddleton DM. Journal of the American
Chemical Society 2004;126(41):13220e1.
[212] Samanta D, McRae S, Cooper B, Hu YX, Emrick T. Biomacromolecules 2008;9
(10):2891e7.
[213] Lewis A, Tang YQ, Brocchini S, Choi JW, Godwin A. Bioconjugate Chemistry
2008;19(11):2144e55.
[214] Zarafshani Z, Obata T, Lutz JF. Biomacromolecules 2010;11(8):2130e5.
[215] Siegwart DJ, Oh JK, Gao HF, Bencherif SA, Perineau F, Bohaty AK, et al.
Macromolecular Chemistry and Physics 2008;209(21):2180e93.
[216] Shi W, Dolai S, Averick S, Fernando SS, Saltos JA, L’Amoreaux W, et al. Bio-
conjugate Chemistry 2009;20(8):1595e601.
[217] Bontempo D, Maynard HD. Journal of the American Chemical Society
2005;127(18):6508e9.
[218] Maynard HD, Heredia KL, Li RC, Parra DP, Vazquez-Dorbatt V. Journal of
Materials Chemistry 2007;17:4015e7.
G. Jutz, A. Böker / Polymer 52 (2011) 211e232232[219] Mougin NC, Müller AHE, Böker A. Polymeric Materials: Science and Engi-
neering 2008;99:713.
[220] Pound G, McKenzie JM, Lange RFM, Klumperman B. Chemical Communica-
tions 2008;27:3193e5.
[221] Bathﬁeld M, D’Agosto F, Spitz R, Charreyre MT, Delair T. Journal of the
American Chemical Society 2006;128(8):2546e7.
[222] Wiss KT, Krishna OD, Roth PJ, Kiick KL, Theato P. Macromolecules 2009;42
(12):3860e3.
[223] RothPJ, JochumFD, Zentel R, TheatoP. Biomacromolecules2010;11(1):238e44.
[224] Bays E, Tao L, Chang C-W, Maynard HD. Biomacromolecules 2009;10(7):
1777e81.
[225] Heredia KL, Grover GN, Tao L, Maynard HD. Macromolecules 2009;42(7):
2360e7.
[226] Heredia KL, Tao L, Grover GN, Maynard HD. Polymer Chemistry 2010;1(2):
168e70.
[227] Tao L, Kaddis CS, Loo RRO, Grover GN, Loo JA, Maynard HD. Chemical
Communications 2009;16:2148e50.
[228] Heredia KL, Nguyen TH, Chang CW, Bulmus V, Davis TP, Maynard HD.
Chemical Communications 2008;28:3245e7.
[229] Li M, De P, Gondi SR, Sumerlin BS. Macromolecular Rapid Communications
2008;29(12e13):1172e6.
[230] Boyer C, Liu J, Bulmus V, Davis TP, Barner-Kowollik C, Stenzel MH. Macro-
molecules 2008;41(15):5641e50.
[231] Depp V, Alikhani A, Grammer V, Lele BS. Acta Biomaterialia 2009;5(2):560e9.
[232] Magnusson JP, Bersani S, Salmaso S, Alexander C, Caliceti P. Bioconjugate
Chemistry 2010;21(4):671e8.
[233] Le Droumaguet B, Velonia K. Angewandte Chemie-International Edition
2008;47(33):6263e6.
[234] Gao WP, Liu WG, Christensen T, Zalutsky MR, Chilkoti A. Proceedings of the
National Academy of Sciences of the United States of America 2010;107
(38):16432e7.
[235] Boyer C, Bulmus V, Liu JQ, Davis TP, Stenzel MH, Barner-Kowollik C. Journal
of the American Chemical Society 2007;129(22):7145e54.
[236] De P, Li M, Gondi SR, Sumerlin BS. Journal of the American Chemical Society
2008;130(34):11288e9.
[237] Hentschel J, Bleek K, Ernst O, Lutz JF, Borner HG. Macromolecules 2008;41
(4):1073e5.
[238] Raja KS, Wang Q, Gonzalez MJ, Manchester M, Johnson JE, Finn MG. Bio-
macromolecules 2003;4(3):472e6.
[239] Connor RE, Tirrell DA. Polymer Reviews 2007;47(1):9e28.
[240] Peeler JC, Woodman BF, Averick S, Miyake-Stoner SJ, Stokes AL, Hess KR,
et al. Journal of the American Chemical Society 2010;132(39):13575e7.
[241] Lim YB, Moon KS, Lee M. Chemical Society Reviews 2009;38(4):925e34.
[242] Ulijn RV, Woolfson DN. Chemical Society Reviews 2010;39(9):3349e50.
[243] Cui HG, Webber MJ, Stupp SI. Biopolymers 2010;94(1):1e18.
[244] Ma PX. Advanced Drug Delivery Reviews 2008;60(2):184e98.
[245] Mata A, Geng YB, Henrikson KJ, Aparicio C, Stock SR, Satcher RL, et al.
Biomaterials 2010;31(23):6004e12.
[246] Gungormus M, Branco M, Fong H, Schneider JP, Tamerler C, Sarikaya M.
Biomaterials 2010;31(28):7266e74.
[247] Lim YB, Lee E, Yoon YR, Lee MS, Lee M. Angewandte Chemie-International
Edition 2008;47(24):4525e8.
[248] Roldao A, Mellado MCM, Castilho LR, Carrondo MJT, Alves PM. Expert Review
of Vaccines 2010;9(10):1149e76.
[249] Ludwig C, Wagner R. Current Opinion in Biotechnology 2007;18(6):537e45.
[250] Singh P, Prasuhn D, Yeh RM, Destito G, Rae CS, Osborn K, et al. Journal of
Controlled Release 2007;120(1e2):41e50.
[251] McCormick AA, Palmer KE. Expert Review of Vaccines 2008;7(1):33e41.
[252] Miermont A, Barnhill H, Strable E, Lu X, Wall KA, Wang Q, et al. Chemistry e
A European Journal 2008;14(16):4939e47.
[253] Kameta N, Masuda M, Minamikawa H, Mishima Y, Yamashita I, Shimizu T.
Chemistry of Materials 2007;19(14):3553e60.
[254] Gonzalez MJ, Plummer EM, Rae CS, Manchester M. PLoS One 2009;4(11).
Article No.: e7981.
[255] Smith ML, Fitzmaurice WP, Turpen TH, Palmer KE. Plant-Produced Microbial
Vaccines 2009;332:13e31.
[256] Cormode DP, Jarzyna PA, Mulder WJM, Fayad ZA. Advanced Drug Delivery
Reviews 2010;62(3):329e38.
[257] Uchida M, Terashima M, Cunningham CH, Suzuki Y, Willits DA, Willis AF,
et al. Magnetic Resonance in Medicine 2008;60(5):1073e81.
[258] Sanchez P, Valero E, Galvez N, Dominguez-Vera JM, Marinone M, Poletti G,
et al. Dalton Transactions 2009;5:800e4.
[259] Flenniken ML, Liepold LO, Crowley BE, Willits DA, Young MJ, Douglas T.
Chemical Communications (Cambridge, United Kingdom) 2005;4:447e9.
[260] Destito G, Yeh R, Rae CS, Finn MG, Manchester M. Chemistry & Biology
(Cambridge, MA, United States) 2007;14(10):1152e62.
[261] Kaltgrad E, Gupta SS, Punna S, Huang C-Y, Chang A, Wong C-H, et al.
ChemBioChem 2007;8(12):1455e62.[262] Kaltgrad E, O’Reilly MK, Liao L, Han S, Paulson JC, Finn MG. Journal of the
American Chemical Society 2008;130(14):4578e9.
[263] Banerjee D, Liu AP, Voss NR, Schmid SL, Finn MG. Chembiochem 2010;11
(9):1273e9.
[264] Suh WH, Suh YH, Stucky GD. Nano Today 2009;4(1):27e36.
[265] Rowe MD, Thamm DH, Kraft SL, Boyes SG. Biomacromolecules 2009;10
(4):983e93.
[266] Li F, Zhang ZP, Peng J, Cui ZQ, Pang DW, Li K, et al. Small 2009;5(6):718e26.
[267] Xie H, Li YF, Kagawa HK, Trent JD, Mudalige K, Cotlet M, et al. Small 2009;5
(9):1036e42.
[268] Lee SH, Lee H, Park JS, Choi H, Han KY, Seo HS, et al. FASEB Journal 2007;21
(7):1324e34.
[269] Liu G, Wu H, Dohnalkova A, Lin Y. Analytical Chemistry 2007;79(15):5614e9.
[270] Yamada K, Yoshii S, Kumagai S, Miura A, Uraoka Y, Fuyuki T, et al. Japanese
Journal of Applied Physics, Part 1: Regular Papers, Brief Communications &
Review Papers 2007;46(11):7549e53.
[271] OharaK, Yamashita I, UraokaY. Japanese Journal of Applied Physics 2010;49(4).
[272] Miura A, Uraoka Y, Fuyuki T, Yoshii S, Yamashita I. Journal of Applied Physics
2008;103(7, Pt. 1). 074503/074501-074503/074510.
[273] Miura A, Tsukamoto R, Yoshii S, Yamashita I, Uraoka Y, Fuyuki T. Nano-
technology 2008;19(25).
[274] Kubota T, Baba T, Samukawa S, Kawashima H, Uraoka Y, Fuyuki T, et al.
Applied Physics Letters 2004;84(9):1555e7.
[275] Kubota T, Baba T, Saito S, Yamasaki S, Kumagai S, Matsui T, et al. Journal of
Vacuum Science & Technology B 2007;25(3):760e6.
[276] Kubota T, Hashimoto T, Takeguchi M, Nishioka K, Uraoka Y, Fuyuki T, et al.
Journal of Applied Physics 2007;101(12).
[277] Tempel H, Joshi R, Schneider JJ. Materials Chemistry and Physics 2010;121
(1e2):178e83.
[278] Kim I, Hosein H-A, Strongin DR, Douglas T. Chemistry of Materials 2002;14
(11):4874e9.
[279] Varpness Z, Peters JW, Young M, Douglas T. Nano Letters 2005;5(11):
2306e9.Günther Jutz studied Chemistry with Macromolecular
Chemistry as a major subject at the University of Bayreuth.
End of 2008, he received his Ph.D. under the supervision of
Prof. Alexander Böker with a research work on mineralized
bionanoparticle stabilized Pickering emulsions. His
research interests reach from controlled polymerization
techniques to viruses and proteins as building blocks in
bionanotechnology and bio-(in)organic composite mate-
rials. After a visit in the group of Prof. José Carlos Rodriguez
Cabello, University of Valladolid, Spain, he joined SGL
Carbon GmbH, working now on the development of
carbon and graphite materials for energy storage systems.Alexander Böker is Full Professor at the RWTH Aachen
University, holding the Chair for Macromolecular Materials
and Surfaces and serving as Co-Director of the DWI an der
RWTH Aachen e.V. He studied Chemistry at the Cornell
University (Ithaca, NY, USA) and the University of Mainz,
Germany, where he received his Diploma in Chemistry in
1999. In 2002 he completed his Ph.D. in Physical and
Macromolecular Chemistry at the University of Bayreuth,
Germany. From 2002 to 2004 he worked with Thomas P.
Russell at the University of Massachusetts, Amherst, USA.
After his return to Bayreuth, he was awarded a Lichten-
berg-Professorship for Colloid Chemistry funded by the
VolkswagenStiftung in 2006 and qualiﬁed as a professor
for physical chemistry in 2007.His main research interests
include guided self-assembly of block copolymer systems,
hierarchical nanoparticle assemblies and the control of
self-assembly processes via external ﬁelds.
